List of Pharmacological Classifications

A: Alimentary Tract and Metabolism

• A01: Stomatological preparations

  • A01A: Stomatological preparations

    • A01AA: Caries prophylactic agents

      • Sodium Fluoride

    • A01AB: Antiinfectives and antiseptics for local oral treatment

      • Chlorhexidine

      • Choline Salicylate + Cetylpyridinium

      • Minocycline

    • A01AC: Corticosteroids for local oral treatment

      • Chlorhexidine + Lidocaine + Triamcinolone

      • Dexamethasone

      • Lidocaine + Triamcinolone

      • Triamcinolone

    • A01AD: Other agents for local oral treatment

      • Aminacrine + Lidocaine

      • Benzalkonium + Choline Salicylate

      • Benzydamine

      • Benzydamine + Cetylpyridinium

      • Benzydamine + Chlorhexidine

      • Cetalkonium Chloride + Choline Salicylate

      • Cetylpyridinium + Lidocaine

      • Dichlorobenzyl Alcohol + Benzydamine + Lidocaine

• A02: Drugs for acid related disorders

  • A02A: Antacids

    • A02AA: Magnesium compounds

    • A02AB: Aluminium compounds

      • Aluminium Hydroxide

      • Aluminium Oxide

    • A02AC: Calcium compounds

    • A02AD: Combinations and complexes of aluminium, calcium and magnesium compounds

      • Aluminium Hydroxide + Magnesium Trisilicate

      • Calcium Carbonate + Magnesium Carbonate

    • A02AF: Antacids with antiflatulents

      • Aluminium Hydroxide + Dimethicone + Magnesium Hydroxide

      • Aluminium Hydroxide + Dimethicone + Magnesium Oxide

      • Aluminium Hydroxide + Magnesium Carbonate + Dicycloverine + Dimethicone

      • Aluminium Hydroxide + Magnesium Carbonate + Dicycloverine + Simeticone

      • Aluminium Hydroxide + Magnesium Hydroxide + Simeticone

      • Aluminium Hydroxide + Magnesium Trisilicate + Simeticone

      • Aluminum Hydroxide + Dimethicone + Magnesium Hydroxide + Simeticone

      • Citric Acid + Simeticone + Sodium Bicarbonate

    • A02AG: Antacids with antispasmodics

      • Aluminium Hydroxide + Magnesium Carbonate + Dicycloverine + Dimethicone

    • A02AH: Antacids with sodium bicarbonate

    • A02AX: Antacids, other combinations

  • A02B: Drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)

    • A02BA: H2-receptor antagonists

      • Cimetidine

      • Famotidine

      • Ranitidine

    • A02BB: Prostaglandins

      • Misoprostol

    • A02BC: Proton pump inhibitors

      • Dexlansoprazole

      • Esomeprazole

      • Omeprazole

      • Pantoprazole

      • Rabeprazole

      • Tegoprazan

      • Vonoprazan

    • A02BD: Combinations for eradication of Helicobacter pylori

    • A02BX: Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)

      • Aluminium Hydroxide + Biodiastase + Methylmethionine Sulfonium Chloride

      • Potassium Bicarbonate + Sodium Alginate

      • Sodium Alginate + Sodium Bicarbonate + Calcium Carbonate

      • Sucralfate

  • A02X: Other drugs for acid related disorders

• A03: Drugs for functional gastrointestinal disorders

  • A03A: Drugs for functional gastrointestinal disorders

    • A03AA: Synthetic anticholinergics, esters with tertiary amino group

      • Mebeverine

      • Trimebutine

    • A03AB: Synthetic anticholinergics, quaternary ammonium compounds

    • A03AC: Synthetic antispasmodics, amides with tertiary amines

    • A03AD: Papaverine and derivatives

    • A03AE: Serotonin receptor antagonists

    • A03AX: Other drugs for functional gastrointestinal disorders

      • Alverine + Simeticone

      • Dicycloverine + Simeticone

      • Peppermint Oil

      • Simeticone

  • A03B: Belladonna and derivatives, plain

    • A03BA: Belladonna alkaloids, tertiary amines

      • Atropine

    • A03BB: Belladonna alkaloids, semisynthetic, quaternary ammonium compounds

      • Hyoscine Butylbromide

  • A03C: Antispasmodics in combination with psycholeptics

    • A03CA: Synthetic anticholinergic agents in combination with psycholeptics

      • Clidinium + Chlordiazepoxide

    • A03CB: Belladonna and derivatives in combination with psycholeptics

    • A03CC: Other antispasmodics in combination with psycholeptics

  • A03D: Antispasmodics in combination with analgesics

    • A03DA: Synthetic anticholinergic agents in combination with analgesics

    • A03DB: Belladonna and derivatives in combination with analgesics

    • A03DC: Other antispasmodics in combination with analgesics

  • A03E: Antispasmodics and anticholinergics in combination with other drugs

    • A03EA: Antispasmodics, psycholeptics and analgesics in combination

    • A03ED: Antispasmodics in combination with other drugs

      • Dicycloverine + Simeticone

  • A03F: Propulsives

    • A03FA: Propulsives

      • Domperidone

      • Metoclopramide

• A04: Antiemetics and antinauseants

  • A04A: Antiemetics and antinauseants

    • A04AA: Serotonin (5HT3) antagonists

      • Fosnetupitant + Palonosetron

      • Granisetron

      • Netupitant + Palonosetron

      • Ondansetron

      • Palonosetron

    • A04AD: Other antiemetics

      • Aprepitant

      • Fosaprepitant

• A05: Bile and liver therapy

  • A05A: Bile therapy

    • A05AA: Bile acids and derivatives

      • Ursodeoxycholic Acid

    • A05AB: Preparations for biliary tract therapy

    • A05AX: Other drugs for bile therapy

  • A05B: Liver therapy, lipotropics

    • A05BA: Liver therapy

      • L-Ornithine-L-Aspartate

  • A05C: Drugs for bile therapy and lipotropics in combination

• A06: Drugs for constipation

  • A06A: Drugs for constipation

    • A06AA: Softeners, emollients

      • Liquid Paraffin

      • Magnesium Sulfate + Glycerin

    • A06AB: Contact laxatives

      • Aloe + Rhubarb + Senna

      • Bisacodyl

      • Citric Acid + Magnesium Oxide + Sodium Picosulfate

      • Sennosides

    • A06AC: Bulk-forming laxatives

    • A06AD: Osmotically acting laxatives

      • Compound Polyethylene Glycol

      • Dibasic Sodium Phosphate + Monobasic Sodium Phosphate

      • Lactulose

      • Macrogol

    • A06AG: Enemas

      • Dibasic Sodium Phosphate + Monobasic Sodium Phosphate

      • Glycerin + Sodium Chloride

      • Glycerin + Sodium Citrate + Sorbitol

      • Sodium Chloride

    • A06AH: Peripheral opioid receptor antagonists

      • Methylnaltrexone

    • A06AX: Other drugs for constipation

      • Elobixibat

      • Glycerol

      • Prucalopride

• A07: Antidiarrheals, intestinal antiinflammatory/antiinfective agents

  • A07A: Intestinal antiinfectives

    • A07AA: Antibiotics

      • Neomycin + Nystatin + Polymyxin B

      • Nystatin

      • Rifaximin

      • Vancomycin

    • A07AB: Sulfonamides

    • A07AC: Imidazole derivatives

    • A07AX: Other intestinal antiinfectives

      • Nifuroxazide

  • A07B: Intestinal adsorbents

    • A07BA: Charcoal preparations

      • Charcoal (activated)

    • A07BB: Bismuth preparations

    • A07BC: Other intestinal adsorbents

      • Diosmectite

      • Kaolin

      • Kaolin + Magnesium Carbonate + Sodium Bicarbonate

      • Kaolin Colloidal

  • A07C: Electrolytes with carbohydrates

    • A07CA: Oral rehydration salt formulations

  • A07D: Antipropulsives

    • A07DA: Antipropulsives

      • Atropine + Diphenoxylate

      • Loperamide

  • A07E: Intestinal antiinflammatory agents

    • A07EA: Corticosteroids acting locally

      • Budesonide

    • A07EB: Antiallergic agents, excl. corticosteroids

    • A07EC: Aminosalicylic acid and similar agents

      • Mesalazine

      • Sulfasalazine

  • A07F: Antidiarrheal microorganisms

    • A07FA: Antidiarrheal microorganisms

      • Probiotics

      • Saccharomyces boulardii

  • A07X: Other antidiarrheals

    • A07XA: Other antidiarrheals

      • Racecadotril

• A08: Antiobesity preparations, excl. diet products

  • A08A: Antiobesity preparations, excl. diet products

    • A08AA: Centrally acting antiobesity products

      • Bupropion + Naltrexone

      • Phentermine

    • A08AB: Peripherally acting antiobesity products

      • Orlistat

    • A08AX: Other antiobesity drugs

• A09: Digestives, incl. enzymes

  • A09A: Digestives, incl. enzymes

    • A09AA: Enzyme preparations

      • Digestive Enzymes

    • A09AB: Acid preparations

    • A09AC: Enzyme and acid preparations, combinations

• A10: Drugs used in diabetes

  • A10A: Insulins and analogues

    • A10AB: Insulins and analogues for injection, fast-acting

      • Insulin Aspart [Fiasp]

      • Insulin Aspart [Kirsty™]

      • Insulin Aspart [Novorapid]

      • Insulin Aspart

      • Insulin Glulisine [Apidra]

      • Insulin Glulisine

      • Insulin Lispro [Humalog]

      • Insulin Lispro

      • Insulin Soluble (Human) [Actrapid]

      • Insulin Soluble (Human)

    • A10AC: Insulins and analogues for injection, intermediate-acting

      • Insulin Isophane (Human) [Insulatard]

      • Insulin Isophane (Human)

    • A10AD: Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting

      • Insulin Aspart + Insulin Aspart Protamine [Novomix]

      • Insulin Aspart + Insulin Aspart Protamine

      • Insulin Aspart + Insulin Degludec [Ryzodeg®]

      • Insulin Aspart + Insulin Degludec

      • Insulin Lispro + Insulin Lispro Protamine [Humalog Mix]

      • Insulin Lispro + Insulin Lispro Protamine

      • Insulin Soluble (Human) + Insulin Isophane (Human) [Mixtard]

      • Insulin Soluble (Human) + Insulin Isophane (Human)

    • A10AE: Insulins and analogues for injection, long-acting

      • Insulin Degludec [Tresiba®]

      • Insulin Degludec

      • Insulin Detemir [Levemir®]

      • Insulin Detemir

      • Insulin Glargine [Lantus]

      • Insulin Glargine [Semglee™]

      • Insulin Glargine [Toujeo]

      • Insulin Glargine

      • Insulin Glargine + Lixisenatide [Soliqua]

      • Insulin Glargine + Lixisenatide

    • A10AF: Insulins and analogues for inhalation

  • A10B: Blood glucose lowering drugs, excl. insulins

    • A10BA: Biguanides

      • Metformin

    • A10BB: Sulfonylureas

      • Glibenclamide

      • Gliclazide

      • Glimepiride

      • Glipizide

      • Tolbutamide

    • A10BC: Sulfonamides (heterocylic)

    • A10BD: Combinations of oral blood glucose lowering drugs

      • Dapagliflozin + Metformin

      • Dapagliflozin + Sitagliptin

      • Empagliflozin + Linagliptin

      • Empagliflozin + Metformin

      • Glibenclamide + Metformin

      • Linagliptin + Metformin

      • Metformin + Sitagliptin

      • Metformin + Vildagliptin

    • A10BF: Alpha glucosidase inhibitors

      • Acarbose

    • A10BG: Thiazolidinediones

      • Pioglitazone

    • A10BH: Dipeptidyl peptidase 4 (DPP-4) inhibitors

      • Linagliptin

      • Sitagliptin

      • Vildagliptin

    • A10BJ: Glucagon-like peptide-1 (GLP-1) analogues

      • Dulaglutide [Trulicity]

      • Dulaglutide

      • Liraglutide

      • Semaglutide

    • A10BK: Sodium-glucose co-transporter 2 (SGLT2) inhibitors

      • Canagliflozin

      • Dapagliflozin

      • Empagliflozin

    • A10BX: Other blood glucose lowering drugs, excl. insulins

      • Repaglinide

      • Tirzepatide

  • A10X: Other drugs used in diabetes

    • A10XA: Aldose reductase inhibitors

    • A10XX: Other drugs used in diabetes

• A11: Vitamins

  • A11A: Multivitamins, combinations

    • A11AA: Multivitamins with minerals

    • A11AB: Multivitamins, other combinations

  • A11B: Multivitamins, plain

    • A11BA: Multivitamins, plain

  • A11C: Vitamin A and D, incl. combination of the two

    • A11CA: Vitamin A, plain

    • A11CB: Vitamin A and D in combination

    • A11CC: Vitamin D and analogues

      • Alfacalcidol

      • Calcitriol

      • Vitamin D3 (Colecalciferol)

  • A11D: Vitamin B1, plain and in combination with vitamin B6 and B12

    • A11DA: Vitamin B1, plain

      • Sulbutiamine

    • A11DB: Vitamin B1 in combination with vitamin B6 and/or vitamin B12

      • Vitamin B1 + Vitamin B6 + Vitamin B12

  • A11E: Vitamin B-complex, incl. combinations

    • A11EA: Vitamin B-complex, plain

    • A11EB: Vitamin B-complex with vitamin C

    • A11EC: Vitamin B-complex with minerals

    • A11ED: Vitamin B-complex with anabolic steroids

    • A11EX: Vitamin B-complex, other combinations

  • A11G: Ascorbic acid (vitamin C), incl. combinations

    • A11GA: Ascorbic acid (vitamin C), plain

      • Vitamin C (Ascorbic Acid)

    • A11GB: Ascorbic acid (vitamin C), combinations

  • A11H: Other plain vitamin preparations

    • A11HA: Other plain vitamin preparations

  • A11J: Other vitamin products, combinations

    • A11JA: Combinations of vitamins

      • Vitamin B1 + Vitamin B6 + Vitamin B12 + Vitamin E

    • A11JB: Vitamins with minerals

    • A11JC: Vitamins, other combinations

• A12: Mineral supplements

  • A12A: Calcium

    • A12AA: Calcium

    • A12AX: Calcium, combinations with vitamin D and/or other drugs

  • A12B: Potassium

    • A12BA: Potassium

      • Citric Acid Monohydrate + Potassium Citrate

      • Potassium Chloride

      • Potassium Citrate

  • A12C: Other mineral supplements

    • A12CA: Sodium

      • Dextrose + Sodium Chloride

    • A12CB: Zinc

      • Zinc

    • A12CC: Magnesium

      • Magnesium Sulfate

    • A12CD: Fluoride

    • A12CE: Selenium

    • A12CX: Other mineral products

• A13: Tonics

  • A13A: Tonics

• A14: Anabolic agents for systemic use

  • A14A: Anabolic steroids

    • A14AA: Androstan derivatives

      • Oxymetholone

    • A14AB: Estren derivatives

      • Nandrolone Decanoate

  • A14B: Other anabolic agents

• A15: Appetite stimulants

• A16: Other alimentary tract and metabolism products

  • A16A: Other alimentary tract and metabolism products

    • A16AA: Amino acids and derivatives

    • A16AB: Enzymes

      • Agalsidase Alfa [Replagal]

      • Agalsidase Alfa

      • Agalsidase Beta [Fabrazyme®]

      • Agalsidase Beta

      • Alglucosidase Alfa [Myozyme®]

      • Alglucosidase Alfa

      • Asfotase Alfa [Strensiq]

      • Asfotase Alfa

      • Avalglucosidase Alfa [Nexviazyme]

      • Avalglucosidase Alfa

      • Galsulfase [Naglazyme]

      • Galsulfase

      • Idursulfase [Elaprase™]

      • Idursulfase

      • Imiglucerase [Cerezyme®]

      • Imiglucerase

      • Laronidase

      • Pegunigalsidase Alfa [Elfabrio]

      • Pegunigalsidase Alfa

      • Taliglucerase Alfa [Elelyso]

      • Taliglucerase Alfa

      • Velaglucerase Alfa [Vpriv]

      • Velaglucerase Alfa

    • A16AX: Various alimentary tract and metabolism products

B: Blood and blood forming organs

• B01: Antithrombotic agents

  • B01A: Antithrombotic agents

    • B01AA: Vitamin K antagonists

      • Warfarin

    • B01AB: Heparin group

      • Bemiparin

      • Dalteparin

      • Enoxaparin

      • Heparin

      • Heparinised Saline

      • Nadroparin

    • B01AC: Platelet aggregation inhibitors excl. heparin

      • Aspirin

      • Aspirin + Clopidogrel

      • Clopidogrel

      • Dipyridamole

      • Epoprostenol

      • Iloprost

      • Selexipag

      • Ticagrelor

      • Ticlopidine

      • Tirofiban

    • B01AD: Enzymes

      • Alteplase [Actilyse]

      • Alteplase

      • Tenecteplase [Metalyse]

      • Tenecteplase

      • Urokinase [Urokinase-Green Cross]

      • Urokinase

    • B01AE: Direct thrombin inhibitors

      • Dabigatran Etexilate

    • B01AF: Direct factor Xa inhibitors

      • Apixaban

      • Edoxaban

      • Rivaroxaban

    • B01AX: Other antithrombotic agents

      • Fondaparinux

• B02: Antihemorrhagics

  • B02A: Antifibrinolytics

    • B02AA: Amino acids

      • Tranexamic Acid

    • B02AB: Proteinase inhibitors

      • Aprotinin [Trasylol]

      • Aprotinin

  • B02B: Vitamin K and other hemostatics

    • B02BA: Vitamin K

    • B02BB: Fibrinogen

      • Fibrinogen, Human [Fibryga]

      • Fibrinogen, Human [Haemocomplettan P]

      • Fibrinogen, Human

    • B02BC: Local hemostatics

      • Aprotinin + Calcium Chloride + Fibrinogen, Human + Thrombin [Artiss]

      • Aprotinin + Calcium Chloride + Fibrinogen, Human + Thrombin [Tisseel]

      • Aprotinin + Calcium Chloride + Fibrinogen, Human + Thrombin

      • Aprotinin + Calcium Chloride Dihydrate + Human Plasma Coagulation Factor XIII (pd-FXIII) + Fibrinogen, Human + Thrombin [Beriplast]

      • Aprotinin + Calcium Chloride Dihydrate + Human Plasma Coagulation Factor XIII (pd-FXIII) + Fibrinogen, Human + Thrombin

      • Fibrinogen, Human + Thrombin [TachoSil]

      • Fibrinogen, Human + Thrombin [VeraSeal]

      • Fibrinogen, Human + Thrombin

    • B02BD: Blood coagulation factors

      • Coagulation Factor II, IX, VII and X + Protein C + Protein S [Octaplex]

      • Coagulation Factor II, IX, VII and X + Protein C + Protein S

      • Coagulation Factor IX (Human) [AlphaNine SD]

      • Coagulation Factor IX (Human) [Profilnine]

      • Coagulation Factor IX (Human) [Replenine-VF]

      • Coagulation Factor IX (Human)

      • Extended Half-life Recombinant Factor VIII (Rurioctocog Alfa Pegol) [Adynovate]

      • Extended Half-life Recombinant Factor VIII (Rurioctocog Alfa Pegol)

      • Factor Eight Inhibitor Bypassing Activity [FEIBA]

      • Factor Eight Inhibitor Bypassing Activity

      • Plasma-Derived Factor VIII [Beriate]

      • Plasma-Derived Factor VIII [Fanhdi]

      • Plasma-Derived Factor VIII [Haemoctin SDH 1000]

      • Plasma-Derived Factor VIII [Haemoctin SDH 250]

      • Plasma-Derived Factor VIII [Haemoctin SDH 500]

      • Plasma-Derived Factor VIII [Koāte-DVI]

      • Plasma-Derived Factor VIII [Octanate]

      • Plasma-Derived Factor VIII

      • Plasma-Derived Factor VIII + Von Willebrand Factor [Alphanate]

      • Plasma-Derived Factor VIII + Von Willebrand Factor [Optivate]

      • Plasma-Derived Factor VIII + Von Willebrand Factor

      • Recombinant Factor IX [BeneFIX]

      • Recombinant Factor IX [Idelvion]

      • Recombinant Factor IX

      • Recombinant Factor VIIa [NovoSeven®]

      • Recombinant Factor VIIa

      • Recombinant Factor VIII [Advate]

      • Recombinant Factor VIII [Afstyla]

      • Recombinant Factor VIII [NovoEight]

      • Recombinant Factor VIII [Nuwiq]

      • Recombinant Factor VIII [Xyntha]

      • Recombinant Factor VIII

    • B02BX: Other systemic hemostatics

      • Eltrombopag

      • Emicizumab [Hemlibra]

      • Emicizumab

      • Etamsylate

      • Marstacimab [Hympavzi]

      • Marstacimab

      • Romiplostim [Romiplate]

      • Romiplostim

• B03: Antianemic preparations

  • B03A: Iron preparations

    • B03AA: Iron bivalent, oral preparations

      • Ferrous Sodium Citrate

    • B03AB: Iron trivalent, oral preparations

      • Iron Polymaltose

    • B03AC: Iron, parenteral preparations

      • Ferric Carboxymaltose

      • Ferric Derisomaltose

      • Iron Sucrose

    • B03AD: Iron in combination with folic acid

      • Iron Polymaltose + Vitamin B9

    • B03AE: Iron in other combinations

      • Ferrous Sulphate + Multivitamins

  • B03B: Vitamin B12 and folic acid

    • B03BA: Vitamin B12 (cyanocobalamin and analogues)

      • Vitamin B12 (Cyanocobalamin)

      • Vitamin B12 (Mecobalamin)

    • B03BB: Folic acid and derivatives

  • B03X: Other antianemic preparations

    • B03XA: Other antianemic preparations

      • Darbepoetin Alfa [NESP]

      • Darbepoetin Alfa

      • Epoetin Alfa [Eprex]

      • Epoetin Alfa

      • Epoetin Beta [Recormon]

      • Epoetin Beta

      • Luspatercept [Reblozyl]

      • Luspatercept

      • Methoxy Polyethylene Glycol-Epoetin Beta [Mircera]

      • Methoxy Polyethylene Glycol-Epoetin Beta

• B05: Blood substitutes and perfusion solutions

  • B05A: Blood and related products

    • B05AA: Blood substitutes and plasma protein fractions

      • Albumin [Albumin SG]

      • Albumin [Albunorm]

      • Albumin [Alburx]

      • Albumin [Albutein]

      • Albumin [Human Albumin Behring]

      • Albumin [Human Albumin Grifols]

      • Albumin [Plasbumin-25]

      • Albumin [Uman]

      • Albumin [Zenalb]

      • Albumin

      • Electrolytes + Hydroxyethylstarch

      • Gelatin Succinylated + Electrolytes

      • Gelatin Succinylated + Sodium Chloride

      • Hydroxyethylstarch + Sodium Chloride

      • Plasma Proteins (Human) [Plasmanate]

      • Plasma Proteins (Human)

    • B05AX: Other blood products

  • B05B: I.V. solutions

    • B05BA: Solutions for parenteral nutrition

      • Amino Acids

      • Amino Acids + Dextrose + Electrolytes + Lipids

      • Amino Acids + Dextrose + Lipids

      • Dextrose

      • Medium-Chain Triglycerides + Fish Oil + Olive Oil + Soyabean Oil

      • Medium-Chain Triglycerides + Omega-3-Triglycerides + Soyabean Oil

      • Soyabean Oil + Medium-Chain Triglycerides

    • B05BB: Solutions affecting the electrolyte balance

      • Compound Sodium Lactate

      • Dextrose + Potassium Chloride

      • Dextrose + Potassium Chloride + Sodium Chloride

      • Dextrose + Sodium Chloride

      • Electrolytes

      • Electrolytes + Hydroxyethylstarch

      • Electrolytes + Malic Acid

      • Potassium Chloride

      • Potassium Chloride + Sodium Chloride

    • B05BC: Solutions producing osmotic diuresis

      • Mannitol

      • Mannitol + Sorbitol

  • B05C: Irrigating solutions

    • B05CA: Antiinfectives

    • B05CB: Salt solutions

      • Sodium Chloride

    • B05CX: Other irrigating solutions

  • B05D: Peritoneal dialytics

    • B05DA: Isotonic solutions

      • Intraperitoneal Dialysis

    • B05DB: Hypertonic solutions

      • Intraperitoneal Dialysis

  • B05X: I.V. solution additives

    • B05XA: Electrolye solutions

      • Calcium Gluconate

      • Magnesium Sulfate

      • Potassium Acetate

      • Potassium Chloride

      • Potassium Phosphate Monobasic

      • Selenium

      • Sodium Bicarbonate

      • Sodium Chloride

      • Sodium Glycerophosphate

      • Trace Elements

    • B05XB: Amino acids

      • Alanyl Glutamine

    • B05XC: Vitamins

      • Multivitamin for Parenteral

    • B05XX: Other i.v. solution additives

  • B05Z: Hemodialytics and hemofiltrates

    • B05ZA: Hemodialytics, concentrates

      • Haemodialysis Concentrate (For Bicarbonate Dialysis)

      • Sodium Bicarbonate for Haemodialysis

    • B05ZB: Hemofiltrates

      • Continuous Renal Replacement Therapy Solution

      • Hemofiltrates

      • Sodium Chloride + Sodium Citrate

• B06: Other hematological agents

  • B06A: Other hematological agents

    • B06AA: Enzymes

      • Hyaluronidase

    • B06AB: Heme products

    • B06AC: Drugs used in hereditary angioedema

    • B06AX : Other hematological agents

C: Cardiovascular system

• C01: Cardiac therapy

  • C01A: Cardiac glycosides

    • C01AA: Digitalis glycosides

      • Digoxin

    • C01AB: Scilla glycosides

    • C01AC: Strophanthus glycosides

    • C01AX: Other cardiac glycosides

  • C01B: Antiarrhythmics, class I and III

    • C01BA: Antiarrhythmics, class Ia

    • C01BB: Antiarrhythmics, class Ib

      • Lidocaine

    • C01BC: Antiarrhythmics, class Ic

      • Flecainide

      • Propafenone

    • C01BD: Antiarrhythmics, class III

      • Amiodarone

      • Dronedarone

    • C01BG: Other antiarrhythmics, class I and III

  • C01C: Cardiac stimulants excl. cardiac glycosides

    • C01CA: Adrenergic and dopaminergic agents

      • Adrenaline

      • Dobutamine

      • Dopamine

      • Ephedrine Hydrochloride

      • Ephedrine Sulfate

      • Midodrine

      • Norepinephrine

      • Phenylephrine

    • C01CE: Phosphodiesterase inhibitors

      • Milrinone

    • C01CX: Other cardiac stimulants

  • C01D: Vasodilators used in cardiac diseases

    • C01DA: Organic nitrates

      • Glyceryl Trinitrate

      • Isosorbide Dinitrate

      • Isosorbide Mononitrate

    • C01DB: Quinolone vasodilators

    • C01DX: Other vasodilators used in cardiac diseases

      • Vericiguat

  • C01E: Other cardiac preparations

    • C01EA: Prostaglandins

      • Alprostadil

    • C01EB: Other cardiac preparations

      • Adenosine

      • Ivabradine

      • Mavacamten

      • Ranolazine

      • Trimetazidine

    • C01EX: Other cardiac combination products

• C02: Antihypertensives

  • C02A: Antiadrenergic agents, centrally acting

    • C02AA: Rauwolfia alkaloids

    • C02AB: Methyldopa

      • Methyldopa

    • C02AC: Imidazoline receptor agonists

  • C02B: Antiadrenergic agents, ganglion-blocking

    • C02BA: Sulfonium derivatives

    • C02BB: Secondary and tertiary amines

    • C02BC: Bisquaternary ammonium compounds

  • C02C: Antiadrenergic agents, peripherally acting

    • C02CA: Alpha-adrenoreceptor antagonists

      • Doxazosin

      • Prazosin

    • C02CC: Guanidine derivatives

  • C02D: Arteriolar smooth muscle, agents acting on

    • C02DA: Thiazide derivatives

    • C02DB: Hydrazinophthalazine derivatives

      • Hydralazine

    • C02DC: Pyrimidine derivatives

    • C02DD: Nitroferricyanide derivatives

    • C02DG: Guanidine derivatives

  • C02K: Other antihypertensives

    • C02KA: Alkaloids, excl. rauwolfia

    • C02KB: Tyrosine hydroxylase inhibitors

    • C02KC: MAO inhibitors

    • C02KD: Serotonin antagonists

    • C02KN: Other antihypertensives

    • C02KX: Antihypertensives for pulmonary arterial hypertension

      • Ambrisentan

      • Bosentan

      • Macitentan

      • Riociguat

      • Sotatercept [Winrevair®]

      • Sotatercept

  • C02L: Antihypertensives and diuretics in combination

    • C02LA: Rauwolfia alkaloids and diuretics in combination

    • C02LB: Methyldopa and diuretics in combination

    • C02LC: Imidazoline receptor agonists in combination with diuretics

    • C02LE: Alpha-adrenoreceptor antagonists and diuretics

    • C02LF: Guanidine derivatives and diuretics

    • C02LG: Hydrazinophthalazine derivatives and diuretics

    • C02LK: Alkaloids, excl. rauwolfia, in combination with diuretics

    • C02LL: MAO inhibitors and diuretics

    • C02LN: Serotonin antagonists and diuretics

    • C02LX: Other antihypertensives and diuretics

  • C02N: Combinations of antihypertensives in ATC-gr. C02

• C03: Diuretics

  • C03A: Low-ceiling diuretics, thiazides

    • C03AA: Thiazides, plain

      • Hydrochlorothiazide

    • C03AB: Thiazides and potassium in combination

    • C03AH: Thiazides, combinations with psycholeptics and/or analgesics

    • C03AX: Thiazides, combinations with other drugs

  • C03B: Low-ceiling diuretics, excl. thiazides

    • C03BA: Sulfonamides, plain

      • Indapamide

    • C03BB: Sulfonamides and potassium in combination

    • C03BC: Mercurial diuretics

    • C03BD: Xanthine derivatives

    • C03BK: Sulfonamides, combinations with other drugs

    • C03BX: Other low-ceiling diuretics

  • C03C: High-ceiling diuretics

    • C03CA: Sulfonamides, plain

      • Bumetanide

      • Furosemide

    • C03CB: Sulfonamides and potassium in combination

    • C03CC: Aryloxyacetic acid derivatives

    • C03CD: Pyrazolone derivatives

    • C03CX: Other high-ceiling diuretics

  • C03D: Aldosterone antagonists and other potassium-sparing agents

    • C03DA: Aldosterone antagonists

      • Eplerenone

      • Finerenone

      • Spironolactone

    • C03DB: Other potassium-sparing agents

  • C03E: Diuretics and potassium-sparing agents in combination

    • C03EA: Low-ceiling diuretics and potassium-sparing agents

      • Amiloride + Hydrochlorothiazide

      • Triamterene + Hydrochlorothiazide

    • C03EB: High-ceiling diuretics and potassium-sparing agents

  • C03X: Other diuretics

    • C03XA: Vasopressin antagonists

      • Tolvaptan

• C04: Peripheral vasodilators

  • C04A: Peripheral vasodilators

    • C04AA: 2-amino-1-phenylethanol derivatives

    • C04AB: Imidazoline derivatives

    • C04AC: Nicotinic acid and derivatives

    • C04AD: Purine derivatives

      • Pentoxifylline

    • C04AE: Ergot alkaloids

    • C04AF: Enzymes

    • C04AX: Other peripheral vasodilators

• C05: Vasoprotectives

  • C05A: Agents for treatment of hemorrhoids and anal fissures for topical use

    • C05AA: Corticosteroids

      • Aesculin + Cinchocaine + Framycetin + Hydrocortisone

    • C05AB: Antibiotics

    • C05AD: Local anesthetics

      • Procaine

    • C05AE: Muscle relaxants

      • Glyceryl Trinitrate

    • C05AX: Other agents for treatment of hemorrhoids and anal fissures for topical use

  • C05B: Antivaricose therapy

    • C05BA: Heparins or heparinoids for topical use

      • Mucopolysaccharide Polysulphate

    • C05BB: Sclerosing agents for local injection

      • Phenol (in Almond Oil)

      • Polidocanol

    • C05BX: Other sclerosing agents

  • C05C: Capillary stabilizing agents

    • C05CA: Bioflavonoids

      • Diosmin + Hesperidin

    • C05CX: Other capillary stabilizing agents

  • C05X: Other Vasoprotectives

    • C05XX: Other Vasoprotectives

• C07: Beta blocking agents

  • C07A: Beta blocking agents

    • C07AA: Beta blocking agents, non-selective

      • Propranolol

      • Sotalol

    • C07AB: Beta blocking agents, selective

      • Acebutolol

      • Atenolol

      • Betaxolol

      • Bisoprolol

      • Metoprolol

      • Nebivolol

    • C07AG: Alpha and beta blocking agents

      • Carvedilol

      • Labetalol

  • C07B: Beta blocking agents and thiazides

    • C07BA: Beta blocking agents, non-selective, and thiazides

    • C07BB: Beta blocking agents, selective, and thiazides

    • C07BG: Alpha and beta blocking agents and thiazides

  • C07C: Beta blocking agents and other diuretics

    • C07CA: Beta blocking agents, non-selective, and other diuretics

    • C07CB: Beta blocking agents, selective, and other diuretics

    • C07CG: Alpha and beta blocking agents and other diuretics

  • C07D: Beta blocking agents, thiazides and other diuretics

    • C07DA: Beta blocking agents, non-selective, thiazides and other diuretics

    • C07DB: Beta blocking agents, selective, thiazides and other diuretics

  • C07E: Beta blocking agents and vasodilators

    • C07EA: Beta blocking agents, non-selective, and vasodilators

    • C07EB: Beta blocking agents, selective, and vasodilators

  • C07F: Beta blocking agents, other combinations

    • C07FB: Beta blocking agents and calcium channel blockers

      • Amlodipine + Bisoprolol

      • Atenolol + Nifedipine

    • C07FX: Beta blocking agents, other combinations

      • Carvedilol + Ivabradine

• C08: Calcium channel blockers

  • C08C: Selective calcium channel blockers with mainly vascular effects

    • C08CA: Dihydropyridine derivatives

      • Amlodipine

      • Felodipine

      • Lacidipine

      • Levamlodipine

      • Nifedipine

      • Nimodipine

    • CO8CX: Other selective calcium channel blockers with mainly vascular effects

  • C08D: Selective calcium channel blockers with direct cardiac effects

    • C08DA: Phenylalkylamine derivatives

      • Verapamil

    • C08DB: Benzothiazepine derivatives

      • Diltiazem

  • C08E: Non-selective calcium channel blockers

    • C08EA: Phenylalkylamine derivatives

    • C08EX: Other non-selective calcium channel blockers

  • C08G: Calcium channel blockers and diuretics

    • C08GA: Calcium channel blockers and diuretics

      • Amlodipine + Indapamide

• C09: Agents acting on the renin-angiotensin system

  • C09A: ACE inhibitors, plain

    • C09AA: ACE inhibitors, plain

      • Captopril

      • Enalapril

      • Imidapril

      • Lisinopril

      • Perindopril Arginine

      • Perindopril Erbumine

      • Ramipril

  • C09B: ACE inhibitors, combinations

    • C09BA: ACE inhibitors and diuretics

      • Enalapril + Hydrochlorothiazide

      • Indapamide + Perindopril Arginine

    • C09BB: ACE inhibitors and calcium channel blockers

      • Amlodipine + Perindopril Arginine

      • Amlodipine + Perindopril Erbumine

    • C09BX: ACE inhibitors, other combinations

      • Amlodipine + Indapamide + Perindopril Arginine

      • Bisoprolol + Perindopril Arginine

  • C09C: Angiotensin II receptor blockers (ARBs), plain

    • C09CA: Angiotensin II receptor blockers (ARBs), plain

      • Candesartan Cilexetil

      • Eprosartan

      • Fimasartan

      • Irbesartan

      • Losartan

      • Olmesartan Medoxomil

      • Telmisartan

      • Valsartan

  • C09D: Angiotensin II Receptor Blockers (ARBs), combinations

    • C09DA: Angiotensin II receptor blockers (ARBs) and diuretics

      • Candesartan Cilexetil + Hydrochlorothiazide

      • Hydrochlorothiazide + Irbesartan

      • Hydrochlorothiazide + Telmisartan

      • Hydrochlorothiazide + Valsartan

      • Losartan + Hydrochlorothiazide

    • C09DB: Angiotensin II receptor blockers (ARBs) and calcium channel blockers

      • Amlodipine + Irbesartan

      • Amlodipine + Losartan

      • Amlodipine + Olmesartan Medoxomil

      • Amlodipine + Telmisartan

      • Amlodipine + Valsartan

    • C09DX: Angiotensin II receptor blockers (ARBs), other combinations

      • Amlodipine + Hydrochlorothiazide + Valsartan

      • Sacubitril + Valsartan

  • C09X: Other agents acting on the renin-angiotensin system

    • C09XA: Renin-inhibitors

    • C09XX: Other agents acting on the renin-angiotensin system

• C10: Lipid modifying agents

  • C10A: Lipid modifying agents, plain

    • C10AA: HMG CoA reductase inhibitors

      • Atorvastatin

      • Lovastatin

      • Pitavastatin

      • Pravastatin

      • Rosuvastatin

      • Simvastatin

    • C10AB: Fibrates

      • Bezafibrate

      • Choline Fenofibrate

      • Fenofibrate

      • Gemfibrozil

      • Pemafibrate

    • C10AC: Bile acid sequestrants

      • Colestyramine

    • C10AD: Nicotinic acid and derivatives

    • C10AX: Other lipid modifying agents

      • Alirocumab [Praluent]

      • Alirocumab

      • Evolocumab [Repatha]

      • Evolocumab

      • Ezetimibe

      • Inclisiran

      • Omega-3-Triglycerides

  • C10B: Lipid modifying agents, combinations

    • C10BA: Combinations of various lipid modifying agents

      • Atorvastatin + Ezetimibe

      • Ezetimibe + Rosuvastatin

      • Ezetimibe + Simvastatin

      • Fenofibrate + Pravastatin

      • Fenofibrate + Simvastatin

    • C10BX: Lipid modifying agents in combination with other drugs

      • Amlodipine + Atorvastatin

      • Amlodipine + Atorvastatin + Perindopril Arginine

      • Aspirin + Atorvastatin + Ramipril

D: Dermatologicals

• D01: Antifungals for dermatological use

  • D01A: Antifungals for topical use

    • D01AA: Antibiotics

    • D01AC: Imidazole and triazole derivatives

      • Beclomethasone + Clotrimazole

      • Bifonazole

      • Clotrimazole

      • Clotrimazole + Hydrocortisone

      • Diflucortolone + Isoconazole

      • Econazole + Triamcinolone

      • Hydrocortisone + Miconazole

      • Isoconazole

      • Ketoconazole

      • Luliconazole

      • Miconazole

      • Sertaconazole

    • D01AE: Other antifungals for topical use

      • Amorolfine

      • Boric Acid + Resorcinol + Phenol

      • Camphor + Denatured Alcohol + Salicylic Acid

      • Glycyrrhetinic Acid + Undecylenic Acid + Zinc Undecylenate

      • Methyl Salicylate + Salicylic Acid

      • Resorcinol + Salicylic Acid

      • Salicylic Acid

      • Selenium

      • Terbinafine

      • Tolnaftate

  • D01B: Antifungals for systemic use

    • D01BA: Antifungals for systemic use

      • Griseofulvin

      • Terbinafine

• D02: Emollients and protectives

  • D02A: Emollients and protectives

    • D02AA: Silicone products

    • D02AB: Zinc products

    • D02AC: Soft paraffin and fat products

      • Benzalkonium + Liquid Paraffin + Triclosan

    • D02AD: Liquid plasters

    • D02AE: Carbamide products

      • Urea

    • D02AF: Salicylic acid preparations

      • Benzoic Acid + Salicylic Acid

      • Benzoic Acid + Salicylic Acid + Sulphur + Titanium Dioxide

      • Benzoic Acid + Sulphur + Salicylic Acid

    • D02AX: Other emollients and protectives

  • D02B: Protectives against UV-radiation

    • D02BA: Protectives against UV-radiation for topical use

    • D02BB: Protectives against UV-radiation for systemic use

• D03: Preparations for treatment of wounds and ulcers

  • D03A: Cicatrizants

    • D03AA: Cod-liver oil ointments

    • D03AX: Other cicatrizants

      • Centella Asiatica Herba + Plectranthus Amboinicus Extract

  • D03B: Enzymes

    • D03BA: Proteolytic enzymes

• D04: Antipruritics, incl. antihistamines, anesthetics, etc.

  • D04A: Antipruritics, incl. antihistamines, anesthetics, etc.

    • D04AA: Antihistamines for topical use

    • D04AB: Anesthetics for topical use

      • Benzocaine

      • Cetrimide + Chlorhexidine + Lidocaine

      • Cetrimide + Lidocaine

      • Lidocaine

    • D04AX: Other antipruritics

      • Crotamiton

• D05: Antipsoriatics

  • D05A: Antipsoriatics for topical use

    • D05AA: Tars

      • Coal Tar

      • Coal Tar + Phenol + Precipitated Sulphur

      • Coal Tar + Salicylic Acid

      • Coal Tar + Salicylic Acid + Tars

      • Cocois Compound

      • Pine Tar

    • D05AC: Antracen derivatives

    • D05AD: Psoralens for topical use

    • D05AX: Other antipsoriatics for topical use

      • Calcipotriol

      • Calcipotriol + Betamethasone

      • Calcitriol

      • Ichthammol

  • D05B: Antipsoriatics for systemic use

    • D05BA: Psoralens for systemic use

    • D05BB: Retinoids for treatment of psoriasis

      • Acitretin

    • D05BX: Other antipsoriatics for systemic use

• D06: Antibiotics and chemotherapeutics for dermatological use

  • D06A: Antibiotics for topical use

    • D06AA: Tetracycline and derivatives

      • Tetracycline

    • D06AX: Other antibiotics for topical use

      • Bacitracin + Neomycin

      • Bacitracin + Neomycin + Polymyxin B

      • Fusidic Acid

      • Gentamicin

      • Mupirocin

  • D06B: Chemotherapeutics for topical use

    • D06BA: Sulfonamides

      • Silver Sulphadiazine + Chlorhexidine

    • D06BB: Antivirals

      • Acyclovir

      • Imiquimod

    • D06BX: Other chemotherapeutics

      • Metronidazole

  • D06C: Antibiotics and chemotherapeutics, combinations

• D07: Corticosteroids, dermatological preparations

  • D07A: Corticosteroids, plain

    • D07AA: Corticosteroids, weak (group I)

      • Hydrocortisone

    • D07AB: Corticosteroids, moderately potent (group II)

      • Desonide

      • Triamcinolone

    • D07AC: Corticosteroids, potent (group III)

      • Betamethasone Dipropionate

      • Betamethasone Valerate

      • Fluocinolone

      • Fluticasone Propionate

      • Hydrocortisone

      • Mometasone

    • D07AD: Corticosteroids, very potent (group IV)

      • Clobetasol

  • D07B: Corticosteroids, combinations with antiseptics

    • D07BA: Corticosteroids, weak, combinations with antiseptics

      • Hydrocortisone + Clioquinol

    • D07BB: Corticosteroids, moderately potent, combinations with antiseptics

    • D07BC: Corticosteroids, potent, combinations with antiseptics

      • Betamethasone Valerate + Clioquinol

    • D07BD: Corticosteroids, very potent, combinations with antiseptics

  • D07C: Corticosteroids, combinations with antibiotics

    • D07CA: Corticosteroids, weak, combinations with antibiotics

      • Fusidic Acid + Hydrocortisone

      • Hydrocortisone + Neomycin

    • D07CB: Corticosteroids, moderately potent, combinations with antibiotics

    • D07CC: Corticosteroids, potent, combinations with antibiotics

      • Betamethasone Dipropionate + Clotrimazole + Gentamicin

      • Betamethasone Dipropionate + Fusidic Acid

      • Betamethasone Dipropionate + Gentamicin

      • Betamethasone Valerate + Fusidic Acid

      • Betamethasone Valerate + Gentamicin

      • Betamethasone Valerate + Gentamicin + Miconazole

      • Betamethasone Valerate + Neomycin

    • D07CD: Corticosteroids, very potent, combinations with antibiotics

  • D07X: Corticosteroids, other combinations

    • D07XA: Corticosteroids, weak, other combinations

      • Hydrocortisone + Urea

    • D07XB: Corticosteroids, moderately potent, other combinations

    • D07XC: Corticosteroids, potent, other combinations

      • Betamethasone Dipropionate + Salicylic Acid

      • Betamethasone Valerate + Salicylic Acid

    • D07XD: Corticosteroids, very potent, other combinations

• D08: Antiseptics and disinfectants

  • D08A: Antiseptics and disinfectants

    • D08AA: Acridine derivatives

    • D08AB: Aluminium agents

    • D08AC: Biguanides and amidines

    • D08AD: Boric acid products

    • D08AE: Phenol and derivatives

    • D08AF: Nitrofuran derivatives

    • D08AG: Iodine products

      • Povidone-Iodine

    • D08AH: Quinoline derivatives

    • D08AJ: Quaternary ammonium compounds

    • D08AK: Mercurial products

    • D08AL: Silver products

    • D08AX: Other antiseptics and disinfectants

• D09: Medicated dressings

  • D09A: Medicated dressings

    • D09AA: Medicated dressings with antiinfectives

    • D09AB: Zinc bandages

    • D09AX: Soft paraffin dressings

• D10: Anti-acne preparations

  • D10A: Anti-acne preparations for topical use

    • D10AA: Corticosteroids, combinations for treatment of acne

    • D10AB: Preparations containing sulfur

    • D10AD: Retinoids for topical use in acne

      • Adapalene

      • Adapalene + Benzoyl Peroxide

      • Tretinoin

      • Trifarotene

    • D10AE: Peroxides

      • Adapalene + Benzoyl Peroxide

    • D10AF: Antiinfectives for treatment of acne

      • Benzoyl Peroxide + Clindamycin

      • Clindamycin

      • Erythromycin

    • D10AX: Other anti-acne preparations for topical use

      • Azelaic Acid

      • Clascoterone

  • D10B: Anti-acne preparations for systemic use

    • D10BA: Retinoids for treatment of acne

      • Isotretinoin

    • D10BX: Other anti-acne preparations for systemic use

• D11: Other dermatological preparations

  • D11A: Other dermatological preparations

    • D11AA: Antihidrotics

    • D11AC: Medicated shampoos

    • D11AE: Androgens for topical use

    • D11AF: Wart and anti-corn preparations

      • Fluorouracil + Salicylic Acid

      • Salicylic Acid + Lactic Acid

    • D11AH: Agents for dermatitis, excluding corticosteroids

      • Abrocitinib

      • Crisaborole

      • Dupilumab [Dupixent]

      • Dupilumab

      • Pimecrolimus

      • Tacrolimus

    • D11AX: Other dermatologicals

      • Brimonidine

      • Calcium Gluconate

      • Deoxycholic Acid

      • Finasteride

      • Fluocinolone + Hydroquinone + Tretinoin

      • Ivermectin

      • Minoxidil

G: Genito urinary system and sex hormones

• G01: Gynecological antiinfectives and antiseptics

  • G01A: Antiinfectives and antiseptics, excl. combinations with corticosteroids

    • G01AA: Antibiotics

      • Metronidazole + Nystatin

      • Nystatin

    • G01AB: Arsenic compounds

    • G01AC: Quinoline derivatives

    • G01AD: Organic acids

    • G01AE: Sulfonamides

    • G01AF: Imidazole derivatives

      • Clotrimazole

      • Isoconazole

      • Metronidazole + Miconazole

      • Sertaconazole

    • G01AG: Triazole derivatives

    • G01AX: Other antiinfectives and antiseptics

      • Povidone-Iodine

  • G01B: Antiinfectives/antiseptics in combination with corticosteroids

    • G01BA: Antibiotics and corticosteroids

    • G01BC: Quinoline derivatives and corticosteroids

    • G01BD: Antiseptics and corticosteroids

    • G01BE: Sulfonamides and corticosteroids

    • G01BF: Imidazole derivatives and corticosteroids

• G02: Other gynecologicals

  • G02A: Uterotonics

    • G02AB: Ergot alkaloids

    • G02AC: Ergot alkaloids and oxytocin incl. analogues, in combination

      • Oxytocin + Ergometrine

    • G02AD: Prostaglandins

      • Carboprost

      • Dinoprostone

      • Gemeprost

    • G02AX: Other uterotonics

  • G02B: Contraceptives for topical use

    • G02BA: Intrauterine contraceptives

    • G02BB: Intravaginal contraceptives

  • G02C: Other gynecologicals

    • G02CA: Sympathomimetics, labour repressants

    • G02CB: Prolactine inhibitors

      • Bromocriptine

      • Cabergoline

    • G02CC: Antiinflammatory products for vaginal administration

    • G02CX: Other gynecologicals

      • Fezolinetant

• G03: Sex hormones and modulators of the genital system

  • G03A: Hormonal contraceptives for systemic use

    • G03AA: Progestogens and estrogens, fixed combinations

      • Chlormadinone + Ethinylestradiol

      • Desogestrel + Ethinylestradiol

      • Drospirenone + Ethinylestradiol

      • Estradiol + Norgestrel

      • Ethinylestradiol + Norelgestromin

      • Levonorgestrel + Ethinylestradiol

    • G03AB: Progestogens and estrogens, sequential preparations

    • G03AC: Progestogens

      • Drospirenone

      • Etonogestrel

      • Levonorgestrel

      • Medroxyprogesterone Acetate

    • G03AD: Emergency contraceptives

      • Levonorgestrel

      • Ulipristal

  • G03B: Androgens

    • G03BA: 3-oxoandrosten (4) derivatives

      • Testosterone

      • Testosterone Cipionate

      • Testosterone Decanoate + Testosterone Isocaproate + Testosterone Phenylpropionate + Testosterone Propionate

      • Testosterone Undecanoate

    • G03BB: 5-androstanon (3) derivatives

      • Mesterolone

  • G03C: Estrogens

    • G03CA: Natural and semisynthetic estrogens, plain

      • Conjugated Oestrogens

      • Estradiol

    • G03CB: Synthetic estrogens, plain

    • G03CC: Estrogens, combinations with other drugs

    • G03CX: Other estrogens

      • Tibolone

  • G03D: Progestogens

    • G03DA: Pregnen (4) derivatives

      • Hydroxyprogesterone Caproate

      • Medroxyprogesterone Acetate

      • Progesterone

    • G03DB: Pregnadien derivatives

      • Dienogest

      • Dydrogesterone

    • G03DC: Estren derivatives

      • Norethisterone

  • G03E: Androgens and female sex hormones in combination

    • G03EA: Androgens and estrogens

    • G03EB: Androgen, progestogen and estrogen in combination

    • G03EK: Androgens and female sex hormones in combination with other drugs

  • G03F: Progestogens and estrogens in combination

    • G03FA: Progestogens and estrogens, fixed combinations

      • Dydrogesterone + Estradiol

      • Estradiol + Norethisterone

    • G03FB: Progestogens and estrogens, sequential preparations

      • Dydrogesterone + Estradiol

      • Estradiol + Norethisterone

  • G03G: Gonadotropins and other ovulation stimulants

    • G03GA: Gonadotropins

      • Choriogonadotropin Alfa [Ovidrel]

      • Choriogonadotropin Alfa

      • Corifollitropin Alfa [Elonva]

      • Corifollitropin Alfa

      • Follitropin Alfa [Gonal-F]

      • Follitropin Alfa

      • Follitropin Alfa + Lutropin Alfa [Pergoveris]

      • Follitropin Alfa + Lutropin Alfa

      • Follitropin Beta [Puregon]

      • Follitropin Beta

      • Follitropin Delta [Rekovelle]

      • Follitropin Delta

      • Human Menopausal Gonadotrophin [Menopur]

      • Human Menopausal Gonadotrophin

      • Lutropin Alfa [Luveris]

      • Lutropin Alfa

    • G03GB: Ovulation stimulants, synthetic

      • Clomiphene

  • G03H: Antiandrogens

    • G03HA: Antiandrogens, plain

      • Cyproterone

    • G03HB: Antiandrogens and estrogens

      • Cyproterone + Ethinylestradiol

  • G03X: Other sex hormones and modulators of the genital system

    • G03XA: Antigonadotropins and similar agents

      • Danazol

    • G03XB: Progesterone receptor modulators

      • Mifepristone

    • G03XC: Selective estrogen receptor modulators

      • Raloxifene

    • G03XX: Other sex hormones and modulators of the genital system

• G04: Urologicals

  • G04B: Urologicals

    • G04BA: Acidifiers

    • G04BC: Urinary concrement solvents

    • G04BD: Drugs for urinary frequency and incontinence

      • Flavoxate

      • Mirabegron

      • Oxybutynin

      • Solifenacin

      • Tolterodine

      • Trospium

    • G04BE: Drugs used in erectile dysfunction

      • Alprostadil

      • Avanafil

      • Sildenafil

      • Tadalafil

    • G04BX: Other urologicals

      • Citric Acid + Sodium Bicarbonate + Sodium Citrate + Tartaric Acid

      • Dapoxetine

  • G04C: Drugs used in benign prostatic hypertrophy

    • G04CA: Alpha-adrenoreceptor antagonists

      • Alfuzosin

      • Dutasteride + Tamsulosin

      • Tamsulosin

      • Terazosin

    • G04CB: Testosterone-5-alpha reductase inhibitors

      • Dutasteride

      • Finasteride

    • G04CX: Other drugs used in benign prostatic hypertrophy

H: Systemic hormonal preparations, excl. sex hormones and insulins

• H01: Pituitary and hypothalamic hormones and analogues

  • H01A: Anterior pituitary lobe hormones and analogues

    • H01AA: ACTH

    • H01AB: Thyrotropin

      • Thyrotropin Alfa [Thyrogen]

      • Thyrotropin Alfa

    • H01AC: Somatropin and somatropin agonists

      • Somatrogon [Ngenla]

      • Somatrogon

      • Somatropin [Genotropin]

      • Somatropin [Norditropin]

      • Somatropin [Saizen]

      • Somatropin [SciTropin A]

      • Somatropin [Zomacton]

      • Somatropin

    • H01AX: Other anterior pituitary lobe hormones and analogues

  • H01B: Posterior pituitary lobe hormones

    • H01BA: Vasopressin and analogues

      • Desmopressin

      • Terlipressin

      • Vasopressin

    • H01BB: Oxytocin and analogues

      • Carbetocin

      • Oxytocin

  • H01C: Hypothalamic hormones

    • H01CA: Gonadotropin-releasing hormones

    • H01CB: Somatostatin and analogues

      • Lanreotide

      • Octreotide

      • Pasireotide

      • Somatostatin

    • H01CC: Anti-gonadotropin-releasing hormones

      • Cetrorelix

      • Ganirelix

• H02: Corticosteroids for systemic use

  • H02A: Corticosteroids for systemic use, plain

    • H02AA: Mineralocorticoids

      • Fludrocortisone

    • H02AB: Glucocorticoids

      • Betamethasone

      • Betamethasone Dipropionate + Betamethasone

      • Dexamethasone

      • Hydrocortisone

      • Methylprednisolone

      • Prednisolone

      • Prednisone

      • Triamcinolone

  • H02B: Corticosteroids for systemic use, combination

    • H02BX: Corticosteroids for systemic use, combinations

  • H02C: Antiadrenal preparations

    • H02CA: Anticorticosteroids

• H03: Thyroid therapy

  • H03A: Thyroid preparations

    • H03AA: Thyroid hormones

      • Levothyroxine

  • H03B: Antithyroid preparations

    • H03BA: Thiouracils

      • Propylthiouracil

    • H03BB: Sulfur-containing imidazole derivatives

      • Carbimazole

      • Thiamazole

    • H03BC: Perchlorates

    • H03BX: Other antithyroid preparations

  • H03C: Iodine therapy

    • H03CA: Iodine therapy

• H04: Pancreatic hormones

  • H04A: Glycogenolytic hormones

    • H04AA: Glycogenolytic hormones

      • Glucagon

• H05: Calcium homeostasis

  • H05A: Parathyroid hormones and analogues

    • H05AA: Parathyroid hormones and analogues

      • Teriparatide [Forteo]

      • Teriparatide [MEGAPTH-G]

      • Teriparatide [Sondelbay]

      • Teriparatide [Teriparatide-Teva]

      • Teriparatide

  • H05B: Anti-parathyroid agents

    • H05BA: Calcitonin preparations

      • Calcitonin (Salmon Synthetic)

    • H05BX: Other anti-parathyroid agents

      • Cinacalcet

      • Etelcalcetide

J: Antiinfectives for systemic use

• J01: Antibacterials for systemic use

  • J01A: Tetracyclines

    • J01AA: Tetracyclines

      • Doxycycline

      • Eravacycline

      • Minocycline

      • Tetracycline

      • Tigecycline

  • J01B: Amphenicols

    • J01BA: Amphenicols

  • J01C: Beta-lactam antibacterials, penicillins

    • J01CA: Penicillins with extended spectrum

      • Amoxicillin

      • Ampicillin

    • J01CE: Beta-lactamase sensitive penicillins

      • Benzylpenicillin

      • Phenoxymethylpenicillin

    • J01CF: Beta-lactamase resistant penicillins

      • Cloxacillin

    • J01CG: Beta-lactamase inhibitors

    • J01CR: Combinations of penicillins, incl. beta-lactamase inhibitors

      • Amoxicillin + Clavulanic Acid

      • Ampicillin + Sulbactam

      • Piperacillin + Tazobactam

      • Sultamicillin

  • J01D: Other beta-lactam antibacterials

    • J01DB: First-generation cephalosporins

      • Cefadroxil

      • Cefalexin

      • Cefazolin

    • J01DC: Second-generation cephalosporins

      • Cefaclor

      • Cefuroxime

    • J01DD: Third-generation cephalosporins

      • Avibactam + Ceftazidime

      • Cefotaxime

      • Ceftazidime

      • Ceftriaxone

    • J01DE: Fourth-generation cephalosporins

      • Cefepime

    • J01DF: Monobactams

      • Aztreonam

    • J01DH: Carbapenems

      • Doripenem

      • Ertapenem

      • Imipenem + Cilastatin

      • Meropenem

    • J01DI: Other cephalosporins and penems

      • Ceftaroline Fosamil

      • Ceftolozane + Tazobactam

  • J01E: Sulfonamides and trimethoprim

    • J01EA: Trimethoprim and derivatives

    • J01EB: Short-acting sulfonamides

    • J01EC: Intermediate-acting sulfonamides

    • J01ED: Long-acting sulfonamides

    • J01EE: Combinations of sulfonamides and trimethoprim, incl. derivatives

      • Sulfamethoxazole + Trimethoprim

  • J01F: Macrolides, lincosamides and streptogramins

    • J01FA: Macrolides

      • Azithromycin

      • Clarithromycin

      • Erythromycin

      • Erythromycin Ethyl Succinate

      • Roxithromycin

    • J01FF: Lincosamides

      • Clindamycin

      • Lincomycin

    • J01FG: Streptogramins

  • J01G: Aminoglycoside antibacterials

    • J01GA: Streptomycins

      • Streptomycin

    • J01GB: Other aminoglycosides

      • Amikacin

      • Gentamicin

      • Kanamycin

  • J01M: Quinolone antibacterials

    • J01MA: Fluoroquinolones

      • Ciprofloxacin

      • Levofloxacin

      • Lomefloxacin

      • Moxifloxacin

      • Norfloxacin

      • Ofloxacin

    • J01MB: Other quinolones

  • J01R: Combinations of antibacterials

    • J01RA: Combinations of antibacterials

  • J01X: Other antibacterials

    • J01XA: Glycopeptide antibacterials

      • Vancomycin

    • J01XB: Polymyxins

    • J01XC: Steroid antibacterials

    • J01XD: Imidazole derivatives

      • Metronidazole

    • J01XE: Nitrofuran derivatives

      • Nitrofurantoin

    • J01XX: Other antibacterials

      • Daptomycin

      • Fosfomycin

      • Linezolid

      • Tedizolid

• J02: Antimycotics for systemic use

  • J02A: Antimyotics for systemic use

    • J02AA: Antibiotics

      • Amphotericin B

    • J02AB: Imidazole derivatives

      • Ketoconazole

    • J02AC: Triazole and tetrazole derivatives

      • Fluconazole

      • Isavuconazole

      • Itraconazole

      • Posaconazole

      • Voriconazole

    • J02AX: Other antimycotics for systemic use

      • Anidulafungin

      • Caspofungin

      • Micafungin

• J04: Antimycobacterials

  • J04A: Drugs for treatment of tuberculosis

    • J04AA: Aminosalicylic acid and derivatives

    • J04AB: Antibiotics

      • Rifampicin

    • J04AC: Hydrazides

      • Isoniazid

    • J04AD: Thiocarbamide derivatives

    • J04AK: Other drugs for treatment of tuberculosis

      • Ethambutol

      • Pyrazinamide

    • J04AM: Combinations of drugs for treatment of tuberculosis

  • J04B: Drugs for treatment of lepra

    • J04BA: Drugs for treatment of lepra

• J05: Antivirals for systemic use

  • J05A: Direct acting antivirals

    • J05AA: Thiosemicarbazones

    • J05AB: Nucleosides and nucleotides excl. reverse transcriptase inhibitors

      • Acyclovir

      • Ganciclovir

      • Remdesivir

      • Valaciclovir

      • Valganciclovir

    • J05AC: Cyclic amines

    • J05AD: Phosphonic acid derivatives

      • Foscarnet

    • J05AE: Protease inhibitors

      • Atazanavir

      • Darunavir

      • Nirmatrelvir + Ritonavir

      • Ritonavir

    • J05AF: Nucleoside and nucleotide reverse transcriptase inhibitors

      • Abacavir

      • Entecavir

      • Lamivudine

      • Tenofovir Alafenamide

      • Tenofovir Disoproxil Fumarate

      • Zidovudine

    • J05AG: Non-nucleoside reverse transcriptase inhibitors

      • Doravirine

      • Efavirenz

      • Etravirine

      • Rilpivirine

    • J05AH: Neuraminidase inhibitors

      • Oseltamivir

      • Zanamivir

    • J05AJ : Integrase inhibitors

    • J05AP: Antivirals for treatment of HCV infections

      • Glecaprevir + Pibrentasvir

      • Ledipasvir + Sofosbuvir

      • Sofosbuvir + Velpatasvir

      • Sofosbuvir + Velpatasvir + Voxilaprevir

    • J05AR: Antivirals for treatment of HIV infections, combinations

      • Abacavir + Dolutegravir + Lamivudine

      • Abacavir + Lamivudine

      • Bictegravir + Emtricitabine + Tenofovir Alafenamide

      • Dolutegravir + Lamivudine

      • Doravirine + Lamivudine + Tenofovir Disoproxil Fumarate

      • Emtricitabine + Rilpivirine + Tenofovir Alafenamide

      • Emtricitabine + Tenofovir Alafenamide

      • Emtricitabine + Tenofovir Disoproxil Fumarate

      • Lamivudine + Zidovudine

      • Lopinavir + Ritonavir

    • J05AX: Other antivirals

      • Baloxavir Marboxil

      • Lenacapavir

      • Letermovir

      • Maraviroc

      • Methisoprinol

• J06: Immune sera and immunoglobulins

  • J06A: Immune sera

    • J06AA: Immune sera

      • Botulinum Antitoxin [BAT]

      • Botulinum Antitoxin

  • J06B: Immunoglobulins

    • J06BA: Immunoglobulins, normal human

      • Immunoglobulins, Normal Human [Flebogamma]

      • Immunoglobulins, Normal Human [Gammagard S/D]

      • Immunoglobulins, Normal Human [Gamunex®-C]

      • Immunoglobulins, Normal Human [Hizentra]

      • Immunoglobulins, Normal Human [Ig Vena]

      • Immunoglobulins, Normal Human [Immunoglobulins SG]

      • Immunoglobulins, Normal Human [Intratect]

      • Immunoglobulins, Normal Human [Kiovig]

      • Immunoglobulins, Normal Human [Octagam]

      • Immunoglobulins, Normal Human [Pentaglobin]

      • Immunoglobulins, Normal Human [Privigen]

      • Immunoglobulins, Normal Human

    • J06BB: Specific immunoglobulins

      • Anti-D (Rh) Immunoglobulin [HyperRHO]

      • Anti-D (Rh) Immunoglobulin

      • Anti-Rabies Immunoglobulin [HyperRAB]

      • Anti-Rabies Immunoglobulin

      • Cytomegalovirus Immunoglobulin [Megalotect CP]

      • Cytomegalovirus Immunoglobulin

      • Hepatitis B Immunoglobulin [Hepatect CP]

      • Hepatitis B Immunoglobulin [HyperHEP B]

      • Hepatitis B Immunoglobulin

      • Tetanus Immunoglobulin (Human) [HyperTET S/D]

      • Tetanus Immunoglobulin (Human) [Igantet]

      • Tetanus Immunoglobulin (Human)

    • J06BC:  Antibacterial monoclonal antibodies

    • J06BD: Antiviral monoclonal antibodies

      • Nirsevimab [Beyfortus]

      • Nirsevimab

      • Palivizumab [Synagis]

      • Palivizumab

• J07: Vaccines

  • J07A: Bacterial vaccines

    • J07AC: Anthrax vaccines

      • Anthrax Antigen Vaccine [Biothrax]

      • Anthrax Antigen Vaccine

    • J07AD: Brucellosis vaccines

    • J07AE: Cholera vaccines

      • Cholera, Inactivated, Whole Cell Vaccine [Dukoral]

      • Cholera, Inactivated, Whole Cell Vaccine

    • J07AF: Diphtheria vaccines

    • J07AG: Hemophilus influenzae B vaccines

      • Haemophilus influenzae type b Vaccine [Hiberix]

      • Haemophilus influenzae type b Vaccine

    • J07AH: Meningococcal vaccines

      • Meningococcus A,C,Y,W-135, Tetravalent Purified Polysaccharides Antigen Conjugated Vaccine [Menactra®]

      • Meningococcus A,C,Y,W-135, Tetravalent Purified Polysaccharides Antigen Conjugated Vaccine [MenQuadfi]

      • Meningococcus A,C,Y,W-135, Tetravalent Purified Polysaccharides Antigen Conjugated Vaccine [Menveo]

      • Meningococcus A,C,Y,W-135, Tetravalent Purified Polysaccharides Antigen Conjugated Vaccine [Nimenrix]

      • Meningococcus A,C,Y,W-135, Tetravalent Purified Polysaccharides Antigen Conjugated Vaccine

      • Meningococcus B, Multicomponent Vaccine [Trumenba]

      • Meningococcus B, Multicomponent Vaccine

    • J07AJ: Pertussis vaccines

      • Recombinant Acellular Pertussis Vaccine [Pertagen®]

      • Recombinant Acellular Pertussis Vaccine

      • Tetanus, Reduced Diphtheria and Acellular Pertussis Vaccine (Tdap) [Adacel®]

      • Tetanus, Reduced Diphtheria and Acellular Pertussis Vaccine (Tdap) [Boostrix]

      • Tetanus, Reduced Diphtheria and Acellular Pertussis Vaccine (Tdap)

      • Tetanus, Reduced Diphtheria and Recombinant Acellular Pertussis Vaccine (Tdap) [Boostagen]

      • Tetanus, Reduced Diphtheria and Recombinant Acellular Pertussis Vaccine (Tdap)

    • J07AK: Plague vaccines

    • J07AL: Pneumococcal vaccines

      • Pneumococcal Conjugate Vaccine [10-valent] (PCV10) [Synflorix]

      • Pneumococcal Conjugate Vaccine [10-valent] (PCV10)

      • Pneumococcal Conjugate Vaccine [13-valent] (PCV13) [Prevenar 13]

      • Pneumococcal Conjugate Vaccine [13-valent] (PCV13)

      • Pneumococcal Conjugate Vaccine [15-valent] [Vaxneuvance®]

      • Pneumococcal Conjugate Vaccine [15-valent]

      • Pneumococcal Conjugate Vaccine [20-valent] [Prevenar 20]

      • Pneumococcal Conjugate Vaccine [20-valent]

      • Pneumococcal Polysaccharide Vaccine [23-valent] (PPSV23) [Pneumovax 23]

      • Pneumococcal Polysaccharide Vaccine [23-valent] (PPSV23)

    • J07AM: Tetanus vaccines

      • Diphtheria & Tetanus Vaccine [Imovax d.T.]

      • Diphtheria & Tetanus Vaccine

      • Tetanus Toxoid Vaccine [Tetavax]

      • Tetanus Toxoid Vaccine

    • J07AN: Tuberculosis vaccines

      • Bacillus Calmette-Guérin Vaccine (BCG) [BCG AJV]

      • Bacillus Calmette-Guérin Vaccine (BCG)

    • J07AP: Typhoid vaccines

      • Typhoid, Purified Polysaccharide Antigen Vaccine [Typhim Vi]

      • Typhoid, Purified Polysaccharide Antigen Vaccine

    • J07AR: Typhus (exanthematicus) vaccines

    • J07AX: Other bacterial vaccines

  • J07B: Viral vaccines

    • J07BA: Encephalitis vaccines

      • Encephalitis, Japanese, Inactivated, Whole Virus Vaccine [Ixiaro]

      • Encephalitis, Japanese, Inactivated, Whole Virus Vaccine

      • Encephalitis, Japanese, Live Attenuated Vaccine [Imojev®]

      • Encephalitis, Japanese, Live Attenuated Vaccine

    • J07BB: Influenza vaccines

      • Influenza Quadrivalent Egg-based Vaccine (INF) [Fluarix Tetra]

      • Influenza Quadrivalent Egg-based Vaccine (INF) [Influvac Tetra]

      • Influenza Quadrivalent Egg-based Vaccine (INF) [VaxigripTetra]

      • Influenza Quadrivalent Egg-based Vaccine (INF)

      • Influenza Trivalent Vaccine (INF) [Influvac]

      • Influenza Trivalent Vaccine (INF)

      • Influenza, Inactivated, Split Virus or Surface Antigen Vaccine [Aflunov]

      • Influenza, Inactivated, Split Virus or Surface Antigen Vaccine [Panvax®]

      • Influenza, Inactivated, Split Virus or Surface Antigen Vaccine

    • J07BC: Hepatitis vaccines

      • Hepatitis A & Hepatitis B Vaccine [Twinrix]

      • Hepatitis A & Hepatitis B Vaccine

      • Hepatitis A, Inactivated, Whole Virus Vaccine [Avaxim]

      • Hepatitis A, Inactivated, Whole Virus Vaccine [Havrix Junior]

      • Hepatitis A, Inactivated, Whole Virus Vaccine [Havrix]

      • Hepatitis A, Inactivated, Whole Virus Vaccine

      • Hepatitis B Vaccine (HepB) - Adult [Engerix-B]

      • Hepatitis B Vaccine (HepB) - Adult

      • Hepatitis B Vaccine (HepB) - Child [Engerix-B]

      • Hepatitis B Vaccine (HepB) - Child

    • J07BD: Measles vaccines

      • Measles, Mumps, Rubella & Varicella Vaccine (MMRV) [Priorix-Tetra]

      • Measles, Mumps, Rubella & Varicella Vaccine (MMRV) [ProQuad]

      • Measles, Mumps, Rubella & Varicella Vaccine (MMRV)

      • Measles, Mumps, Rubella Vaccine (MMR) [M-M-R II]

      • Measles, Mumps, Rubella Vaccine (MMR) [Priorix]

      • Measles, Mumps, Rubella Vaccine (MMR)

    • J07BE: Mumps vaccines

    • J07BF: Poliomyelitis vaccines

      • Poliomyelitis, Trivalent, Inactivated, Whole Virus Vaccine [Imovax]

      • Poliomyelitis, Trivalent, Inactivated, Whole Virus Vaccine

    • J07BG: Rabies vaccines

      • Rabies Virus Vaccine (Inactivated) [Rabipur]

      • Rabies Virus Vaccine (Inactivated)

    • J07BH: Rota virus diarrhea vaccines

      • Rotavirus, Live Attenuated Vaccine [Rotarix]

      • Rotavirus, Live Attenuated Vaccine

      • Rotavirus, Pentavalent, Live, Reassorted Vaccine [RotaTeq]

      • Rotavirus, Pentavalent, Live, Reassorted Vaccine

    • J07BJ: Rubella vaccines

    • J07BK: Varicella zoster vaccines

      • Varicella Vaccine [Varilrix]

      • Varicella Vaccine [Varivax]

      • Varicella Vaccine

      • Zoster, Purified Antigen Vaccine (Recombinant) [Shingrix]

      • Zoster, Purified Antigen Vaccine (Recombinant)

    • J07BL: Yellow fever vaccines

      • Yellow Fever, Live Attenuated Vaccine [Stamaril]

      • Yellow Fever, Live Attenuated Vaccine

    • J07BM: Papillomavirus vaccines

      • Human Papillomavirus Vaccine Types 16 and 18 (HPV2) [Cervarix]

      • Human Papillomavirus Vaccine Types 16 and 18 (HPV2)

      • Papillomavirus (human types 6, 11, 16, 18, 31, 33, 45, 52, 58) Vaccine [Gardasil 9]

      • Papillomavirus (human types 6, 11, 16, 18, 31, 33, 45, 52, 58) Vaccine

      • Papillomavirus (human types 6, 11, 16, 18) Vaccine [Gardasil™]

      • Papillomavirus (human types 6, 11, 16, 18) Vaccine

    • J07BN: Covid-19 vaccines

      • Covid-19, Protein Subunit Vaccine [Nuvaxovid]

      • Covid-19, Protein Subunit Vaccine

      • Covid-19, RNA-based Vaccine [Comirnaty]

      • Covid-19, RNA-based Vaccine [Spikevax]

      • Covid-19, RNA-based Vaccine

    • J07BX: Other viral vaccines

      • Dengue Tetravalent Vaccine [Dengvaxia]

      • Dengue Tetravalent Vaccine

      • Respiratory Syncytial Virus Vaccine [Abrysvo]

      • Respiratory Syncytial Virus Vaccine [Arexvy]

      • Respiratory Syncytial Virus Vaccine

      • Smallpox and Monkeypox Vaccine [Jynneos]

      • Smallpox and Monkeypox Vaccine

      • Smallpox Vaccine [ACAM2000]

      • Smallpox Vaccine

  • J07C: Bacterial and viral vaccines, combined

    • J07CA: Bacterial and viral vaccines, combined

      • Diphtheria, Tetanus, Acellular Pertussis, Poliovirus & Haemophilus influenzae type b Vaccine (DTaP-IPV-Hib) [Infanrix IPV+HiB]

      • Diphtheria, Tetanus, Acellular Pertussis, Poliovirus & Haemophilus influenzae type b Vaccine (DTaP-IPV-Hib) [Pentaxim]

      • Diphtheria, Tetanus, Acellular Pertussis, Poliovirus & Haemophilus influenzae type b Vaccine (DTaP-IPV-Hib)

      • Diphtheria, Tetanus, Acellular Pertussis, Poliovirus, Haemophilus influenzae type b & Hepatitis B Vaccine (DTaP-IPV-Hib-HepB) [Hexaxim]

      • Diphtheria, Tetanus, Acellular Pertussis, Poliovirus, Haemophilus influenzae type b & Hepatitis B Vaccine (DTaP-IPV-Hib-HepB) [Infanrix Hexa]

      • Diphtheria, Tetanus, Acellular Pertussis, Poliovirus, Haemophilus influenzae type b & Hepatitis B Vaccine (DTaP-IPV-Hib-HepB)

      • Tetanus, Reduced Diphtheria and Acellular Pertussis & Inactivated Poliovirus (Tdap-IPV) Vaccine [Adacel®-Polio]

      • Tetanus, Reduced Diphtheria and Acellular Pertussis & Inactivated Poliovirus (Tdap-IPV) Vaccine [Boostrix Polio]

      • Tetanus, Reduced Diphtheria and Acellular Pertussis & Inactivated Poliovirus (Tdap-IPV) Vaccine

  • J07X: Other vaccines

    • J07XA: Parasitic vaccines

L: Antineoplastic and immunomodulating agents

• L01: Antineoplastic agents

  • L01A: Alkylating agents

    • L01AA: Nitrogen mustard analogues

      • Bendamustine

      • Chlorambucil

      • Chlormethine

      • Cyclophosphamide

      • Ifosfamide

      • Melphalan

    • L01AB: Alkyl sulfonates

      • Busulfan

      • Treosulfan

    • L01AC: Ethylene imines

      • Thiotepa

    • L01AD: Nitrosoureas

      • Carmustine

    • L01AG: Epoxides

    • L01AX: Other alkylating agents

      • Dacarbazine

      • Temozolomide

  • L01B: Antimetabolites

    • L01BA: Folic acid analogues

      • Methotrexate

      • Pemetrexed

    • L01BB: Purine analogues

      • Clofarabine

      • Fludarabine

      • Mercaptopurine

    • L01BC: Pyrimidine analogues

      • Azacitidine

      • Capecitabine

      • Cytarabine

      • Fluorouracil

      • Gemcitabine

      • Tegafur + Gimeracil + Oteracil

      • Tegafur + Uracil

      • Trifluridine + Tipiracil

  • L01C: Plant alkaloids and other natural products

    • L01CA: Vinca alkaloids and analogues

      • Vinblastine

      • Vincristine

      • Vinorelbine

    • L01CB: Podophyllotoxin derivatives

      • Etoposide

    • L01CC: Colchicine derivatives

    • L01CD: Taxanes

      • Cabazitaxel

      • Docetaxel

      • Paclitaxel

      • Paclitaxel (albumin-bound nanoparticles)

    • L01CE: Topoisomerase 1 (TOP1) inhibitors

      • Irinotecan Hydrochloride Trihydrate

      • Liposomal Irinotecan

    • L01CX: Other plant alkaloids and natural products

      • Trabectedin

  • L01D: Cytotoxic antibiotics and related substances

    • L01DA: Actinomycines

      • Dactinomycin

    • L01DB: Anthracyclines and related substances

      • Daunorubicin

      • Doxorubicin

      • Idarubicin

      • Mitoxantrone

    • L01DC: Other cytotoxic antibiotics

      • Bleomycin

  • L01E: Protein kinase inhibitors

    • L01EA : BCR-ABL tyrosine kinase inhibitors

    • L01EB : Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors

    • L01EC : B-Raf serine-threonine kinase (BRAF) inhibitors

    • L01ED : Anaplastic lymphoma kinase (ALK) inhibitors

    • L01EE : Mitogen-activated protein kinase (MEK) inhibitors

    • L01EF: Cyclin-dependent kinase (CDK) inhibitors

      • Abemaciclib

      • Palbociclib

      • Ribociclib

    • L01EG : Mammalian target of rapamycin (mTOR) kinase inhibitors

    • L01EH : Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors

    • L01EJ : Janus-associated kinase (JAK) inhibitors

    • L01EK : Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors

    • L01EL: Bruton's tyrosine kinase (BTK) inhibitors

      • Acalabrutinib

      • Ibrutinib

      • Orelabrutinib

      • Zanubrutinib

    • L01EM : Phosphatidylinositol-3-kinase (Pi3K) inhibitors

    • L01EN : Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors

    • L01EX : Other protein kinase inhibitors

  • L01F: Monoclonal antibodies and antibody drug conjugates

    • L01FA: CD20 (Clusters of Differentiation 20) inhibitors

      • Obinutuzumab [Gazyva]

      • Obinutuzumab

      • Rituximab [MabThera]

      • Rituximab [Rixathon]

      • Rituximab [Ruxience]

      • Rituximab [Truxima®]

      • Rituximab

    • L01FB: CD22 (Clusters of Differentiation 22) inhibitors

      • Inotuzumab Ozogamicin [Besponsa]

      • Inotuzumab Ozogamicin

    • L01FC : CD38 (Clusters of Differentiation 38) inhibitors

    • L01FD : HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors

    • L01FE: EGFR (Epidermal Growth Factor Receptor) inhibitors

      • Cetuximab [Erbitux]

      • Cetuximab

      • Panitumumab [Vectibix]

      • Panitumumab

    • L01FF : PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors

    • L01FG : VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors

    • L01FX : Other monoclonal antibodies and antibody drug conjugates

    • L01FY: Combinations of monoclonal antibodies and antibody drug conjugates

      • Nivolumab + Relatlimab [Opdualag]

      • Nivolumab + Relatlimab

      • Pertuzumab + Trastuzumab [Phesgo]

      • Pertuzumab + Trastuzumab

  • L01X: Other antineoplastic agents

    • L01XA: Platinum compounds

      • Carboplatin

      • Cisplatin

      • Oxaliplatin

    • L01XB: Methylhydrazines

    • L01XD: Sensitizers used in photodynamic/radiation therapy

      • Aminolevulinic Acid

      • Methyl Aminolevulinate

    • L01XF : Retinoids for cancer treatment

    • L01XG : Proteasome inhibitors

    • L01XH : Histone deacetylase (HDAC) inhibitors

    • L01XJ: Hedgehog pathway inhibitors

    • L01XK : Poly (ADP-ribose) polymerase (PARP) inhibitors

    • L01XL: Antineoplastic cell and gene therapy

    • L01XM: Isocitrate dehydrogenase (IDH) inhibitors

    • L01XU: Other antineoplastic agents (cont.)

    • L01XX: Other antineoplastic agents

      • Aflibercept [Zaltrap]

      • Aflibercept

      • Anagrelide

      • Arsenic Trioxide

      • Eribulin

      • Hydroxyurea

      • Lurbinectedin

      • Pegaspargase [Oncaspar]

      • Pegaspargase

      • Selinexor

      • Sotorasib

      • Tagraxofusp [Elzonris]

      • Tagraxofusp

      • Venetoclax

    • L01XY: Combinations of antineoplastic agents

• L02: Endocrine therapy

  • L02A: Hormones and related agents

    • L02AA: Estrogens

    • L02AB: Progestogens

      • Megestrol

    • L02AE: Gonadotropin releasing hormone analogues

      • Goserelin

      • Leuprorelin Acetate

      • Triptorelin

    • L02AX: Other hormones

  • L02B: Hormone antagonists and related agents

    • L02BA: Anti-estrogens

      • Elacestrant

      • Fulvestrant

      • Tamoxifen

    • L02BB: Anti-androgens

      • Apalutamide

      • Bicalutamide

      • Darolutamide

      • Enzalutamide

    • L02BG: Aromatase inhibitors

      • Anastrozole

      • Exemestane

      • Letrozole

    • L02BX: Other hormone antagonists and related agents

      • Abiraterone

      • Degarelix

• L03: Immunostimulants

  • L03A: Immunostimulants

    • L03AA: Colony stimulating factors

      • Filgrastim [Accofil]

      • Filgrastim [Neupogen]

      • Filgrastim [Nivestim]

      • Filgrastim [Zarzio]

      • Filgrastim

      • Lipegfilgrastim [Lonquex]

      • Lipegfilgrastim

      • Pegfilgrastim [Fulphila™]

      • Pegfilgrastim [Neulastim]

      • Pegfilgrastim [Pelgraz]

      • Pegfilgrastim

    • L03AB: Interferons

      • Interferon Beta-1a [Rebif]

      • Interferon Beta-1a

      • Peginterferon Alfa-2a [Pegasys]

      • Peginterferon Alfa-2a

      • Ropeginterferon Alfa-2b [Besremi]

      • Ropeginterferon Alfa-2b

    • L03AC: Interleukins

    • L03AX: Other immunostimulants

      • Plerixafor

      • Thymosin Alpha 1 [Zadaxin]

      • Thymosin Alpha 1

• L04: Immunosuppressants

  • L04A: Immunosuppressants

    • L04AA: Selective immunosuppressants

      • Alemtuzumab [Lemtrada]

      • Alemtuzumab

      • Antilymphocyte Immunoglobulin (Horse) [Atgam]

      • Antilymphocyte Immunoglobulin (Horse)

      • Antithymocyte Immunoglobulin (Rabbit) [Grafalon]

      • Antithymocyte Immunoglobulin (Rabbit) [Thymoglobuline]

      • Antithymocyte Immunoglobulin (Rabbit)

      • Apremilast

      • Cladribine

      • Mycophenolate Mofetil

      • Mycophenolate Sodium

    • L04AB: Tumor necrosis factor alpha (TNF-α) inhibitors

      • Adalimumab [Abrilada]

      • Adalimumab [Amgevita]

      • Adalimumab [Hulio]

      • Adalimumab [Humira]

      • Adalimumab [Hyrimoz]

      • Adalimumab [Idacio]

      • Adalimumab [Yuflyma]

      • Adalimumab

      • Etanercept [Enbrel]

      • Etanercept [Nepexto]

      • Etanercept

      • Golimumab [Simponi]

      • Golimumab

      • Infliximab [Ixifi]

      • Infliximab [Remicade]

      • Infliximab [Remsima]

      • Infliximab

    • L04AC: Interleukin inhibitors

      • Basiliximab [Simulect]

      • Basiliximab

      • Guselkumab [Tremfya]

      • Guselkumab

      • Ixekizumab [Taltz]

      • Ixekizumab

      • Risankizumab [Skyrizi]

      • Risankizumab

      • Satralizumab [Enspryng]

      • Satralizumab

      • Secukinumab [Cosentyx]

      • Secukinumab

      • Siltuximab [Sylvant]

      • Siltuximab

      • Spesolimab [Spevigo]

      • Spesolimab

      • Tildrakizumab [Ilumya]

      • Tildrakizumab

      • Tocilizumab [Actemra]

      • Tocilizumab

      • Ustekinumab [Stelara]

      • Ustekinumab

    • L04AD: Calcineurin inhibitors

      • Ciclosporin

      • Tacrolimus

    • L04AE: Sphingosine-1-phosphate (S1P) receptor modulators

      • Etrasimod

      • Fingolimod

      • Ozanimod

      • Siponimod

    • L04AF: Janus-associated kinase (JAK) inhibitors

      • Baricitinib

      • Deucravacitinib

      • Filgotinib

      • Ritlecitinib

      • Tofacitinib

      • Upadacitinib

    • L04AG: Monoclonal antibodies

      • Belimumab [Benlysta]

      • Belimumab

      • Natalizumab [Tysabri]

      • Natalizumab

      • Ocrelizumab [Ocrevus]

      • Ocrelizumab

      • Ofatumumab [Kesimpta]

      • Ofatumumab

      • Vedolizumab [Entyvio]

      • Vedolizumab

    • L04AH: Mammalian target of rapamycin (mTOR) kinase inhibitors

      • Everolimus

      • Sirolimus

    • L04AJ: Complement inhibitors

      • Avacopan

      • Danicopan

      • Eculizumab [Soliris]

      • Eculizumab

      • Ravulizumab [Ultomiris]

      • Ravulizumab

    • L04AK: Dihydroorotate dehydrogenase (DHODH) inhibitors

      • Leflunomide

      • Teriflunomide

    • L04AX: Other immunosuppressants

      • Azathioprine

      • Dimethyl Fumarate

      • Lenalidomide

      • Methotrexate

      • Pirfenidone

      • Pomalidomide

      • Thalidomide

M: Musculo-skeletal system

• M01: Antiinflammatory and antirheumatic products

  • M01A: Antiinflammatory and antirheumatic products, non-steroids

    • M01AA: Butylpyrazolidines

    • M01AB: Acetic acid derivatives and related substances

      • Aceclofenac

      • Diclofenac

      • Indometacin

      • Ketorolac

    • M01AC: Oxicams

      • Meloxicam

      • Piroxicam

    • M01AE: Propionic acid derivatives

      • Dexketoprofen

      • Ibuprofen

      • Ketoprofen

      • Naproxen

    • M01AG: Fenamates

      • Mefenamic Acid

    • M01AH: Coxibs

      • Celecoxib

      • Etoricoxib

      • Parecoxib

    • M01AX: Other antiinflammatory and antirheumatic agents, non-steroids

  • M01B: Antiinflammatory/antirheumatic agents in combination

    • M01BA: Antiinflammatory/antirheumatic agents in combination with corticosteroids

    • M01BX: Other antiinflammatory/antirheumatic agents in combination with other drugs

  • M01C: Specific antirheumatic agents

    • M01CA: Quinolines

    • M01CB: Gold preparations

    • M01CC: Penicillamine and similar agents

      • Penicillamine

    • M01CX: Other specific antirheumatic agents

• M02: Topical products for joints and muscular pain

  • M02A: Topical products for joints and muscular pain

    • M02AA: Antiinflammatory preparations, non-steroids for topical use

      • Diclofenac

      • Flurbiprofen

      • Ketoprofen

      • Piroxicam

    • M02AB: Capsaicin and similar agents

    • M02AC: Preparations with salicylic acid derivatives

    • M02AX: Other topical products for joint and muscular pain

• M03: Muscle relaxants

  • M03A: Muscle relaxants, peripherally acting agents

    • M03AA: Curare alkaloids

    • M03AB: Choline derivatives

      • Suxamethonium

    • M03AC: Other quaternary ammonium compounds

      • Atracurium

      • Cisatracurium

      • Mivacurium

      • Rocuronium

    • M03AX: Other muscle relaxants, peripherally acting agents

      • Botulinum toxin type A complex [Botox]

      • Botulinum toxin type A complex [Dysport]

      • Botulinum toxin type A complex [Nabota]

      • Botulinum toxin type A complex [Xeomin®]

      • Botulinum toxin type A complex

  • M03B: Muscle relaxants, centrally acting agents

    • M03BA: Carbamic acid esters

    • M03BB: Oxazol, thiazine, and triazine derivatives

    • M03BC: Ethers, chemically close to antihistamines

      • Mefenamic Acid + Orphenadrine

      • Orphenadrine

      • Paracetamol + Orphenadrine

    • M03BX: Other centrally acting agents

      • Baclofen

      • Eperisone

  • M03C: Muscle relaxants, directly acting agents

    • M03CA: Dantrolene and derivatives

• M04: Antigout preparations

  • M04A: Antigout preparations

    • M04AA: Preparations inhibiting uric acid production

      • Allopurinol

      • Febuxostat

    • M04AB: Preparations increasing uric acid excretion

      • Benzbromarone

      • Probenecid

    • M04AC: Preparations with no effect on uric acid metabolism

      • Colchicine

    • M04AX: Other antigout preparations

• M05: Drugs for treatment of bone diseases

  • M05B: Drugs affecting bone structure and mineralization

    • M05BA: Bisphosphonates

      • Alendronic Acid

      • Ibandronic Acid

      • Pamidronic Acid

      • Risedronic Acid

      • Zoledronic Acid

    • M05BB: Bisphosphonates, combinations

      • Alendronic Acid + Vitamin D3

    • M05BC: Bone morphogenetic proteins

    • M05BX: Other drugs affecting bone structure and mineralization

      • Burosumab [Crysvita®]

      • Burosumab

      • Denosumab [Prolia]

      • Denosumab [Xgeva]

      • Denosumab

      • Romosozumab [Evenity]

      • Romosozumab

• M09: Other drugs for disorders of the musculo-skeletal system

  • M09A: Other drugs for disorders of the musculo-skeletal system

    • M09AA: Quinine and derivatives

    • M09AB: Enzymes

    • M09AX: Other drugs for disorders of the musculo-skeletal system

      • Hyaluronic Acid

      • Nusinersen

      • Risdiplam

N: Nervous system

• N01: Anesthetics

  • N01A: Anesthetics, general

    • N01AA: Ethers

    • N01AB: Halogenated hydrocarbons

      • Desflurane

      • Isoflurane

      • Sevoflurane

    • N01AF: Barbiturates, plain

    • N01AG: Barbiturates in combination with other drugs

    • N01AH: Opioid anesthetics

      • Alfentanil

      • Fentanyl

      • Remifentanil

    • N01AX: Other general anesthetics

      • Etomidate

      • Ketamine

      • Propofol

  • N01B: Anesthetics, local

    • N01BA: Esters of aminobenzoic acid

    • N01BB: Amides

      • Adrenaline + Mepivacaine

      • Articaine + Adrenaline

      • Bupivacaine

      • Bupivacaine + Adrenaline

      • Cetrimide + Lidocaine

      • Felypressin + Prilocaine

      • Levobupivacaine

      • Lidocaine

      • Lidocaine + Adrenaline

      • Lidocaine + Phenylephrine

      • Lidocaine + Prilocaine

      • Lidocaine + Tetracaine

      • Mepivacaine

      • Prilocaine

      • Ropivacaine

    • N01BC: Esters of benzoic acid

    • N01BX: Other local anesthetics

• N02: Analgesics

  • N02A: Opioids

    • N02AA: Natural opium alkaloids

      • Morphine

      • Naloxone + Oxycodone

      • Oxycodone

    • N02AB: Phenylpiperidine derivatives

      • Fentanyl

      • Pethidine

    • N02AC: Diphenylpropylamine derivatives

    • N02AD: Benzomorphan derivatives

    • N02AE: Oripavine derivatives

    • N02AF: Morphinan derivatives

      • Dinalbuphine Sebacate

    • N02AG: Opioids in combination with antispasmodics

    • N02AJ: Opioids in combination with non-opioid analgesics

      • Dexketoprofen + Tramadol

      • Paracetamol + Tramadol

    • N02AX: Other opioids

      • Tramadol

  • N02B: Other analgesics and antipyretics

    • N02BA: Salicylic acid and derivatives

      • Aspirin

      • Aspirin + Citric Acid + Sodium Bicarbonate

      • Caffeine + Salicylamide

    • N02BB: Pyrazolones

    • N02BE: Anilides

      • Caffeine + Chlorpheniramine + Paracetamol + Phenylephrine

      • Caffeine + Codeine + Paracetamol

      • Caffeine + Guaifenesin + Paracetamol

      • Caffeine + Paracetamol

      • Caffeine + Paracetamol + Phenylephrine

      • Chlorpheniramine + Paracetamol

      • Chlorpheniramine + Paracetamol + Phenylephrine

      • Chlorpheniramine + Paracetamol + Pseudoephedrine

      • Codeine + Paracetamol

      • Dextromethorphan + Paracetamol + Pseudoephedrine

      • Guaifenesin + Paracetamol + Phenylephrine

      • Ibuprofen + Paracetamol

      • Ibuprofen + Paracetamol + Phenylephrine

      • Pamabrom + Paracetamol

      • Paracetamol

      • Paracetamol + Phenylephrine

      • Paracetamol + Phenylephrine + Vitamin C

      • Paracetamol + Pseudoephedrine

    • N02BF: Gabapentinoids

      • Gabapentin

      • Pregabalin

    • N02BG: Other analgesics and antipyretics

      • Methoxyflurane

  • N02C: Antimigraine preparations

    • N02CA: Ergot alkaloids

      • Ergotamine + Caffeine

    • N02CB: Corticosteroid derivatives

    • N02CC: Selective serotonin (5HT1) agonists

      • Eletriptan

      • Naratriptan

      • Sumatriptan

      • Zolmitriptan

    • N02CD: Calcitonin gene-related peptide (CGRP) antagonists

      • Atogepant

      • Eptinezumab [Vyepti]

      • Eptinezumab

      • Erenumab [Aimovig]

      • Erenumab

      • Fremanezumab [Ajovy]

      • Fremanezumab

      • Galcanezumab [Emgality]

      • Galcanezumab

      • Rimegepant

    • N02CX: Other antimigraine preparations

• N03: Antiepileptics

  • N03A: Antiepileptics

    • N03AA: Barbiturates and derivatives

      • Phenobarbitone

    • N03AB: Hydantoin derivatives

      • Phenytoin

    • N03AC: Oxazolidine derivatives

    • N03AD: Succinimide derivatives

    • N03AE: Benzodiazepine derivatives

      • Clonazepam

    • N03AF: Carboxamide derivatives

      • Carbamazepine

      • Rufinamide

    • N03AG: Fatty acid derivatives

      • Valproate

      • Vigabatrin

    • N03AX: Other antiepileptics

      • Lamotrigine

      • Levetiracetam

      • Perampanel

      • Topiramate

• N04: Anti-parkinson drugs

  • N04A: Anticholinergic agents

    • N04AA: Tertiary amines

      • Benzhexol

    • N04AB: Ethers chemically close to antihistamines

    • N04AC: Ethers of tropine or tropine derivatives

      • Benztropine

  • N04B: Dopaminergic agents

    • N04BA: Dopa and dopa derivatives

      • Levodopa + Benserazide

      • Levodopa + Carbidopa

      • Levodopa + Carbidopa + Entacapone

    • N04BB: Adamantane derivatives

      • Amantadine

    • N04BC: Dopamine agonists

      • Bromocriptine

      • Piribedil

      • Pramipexole

      • Ropinirole

    • N04BD: Monoamine oxidase B inhibitors

      • Rasagiline

      • Safinamide

      • Selegiline

    • N04BX: Other dopaminergic agents

      • Entacapone

  • N04C: Other antiparkinson drugs

    • N04CX: Other antiparkinson drugs

• N05: Psycholeptics

  • N05A: Antipsychotics

    • N05AA: Phenothiazines with aliphatic side-chain

      • Chlorpromazine

    • N05AB: Phenothiazines with piperazine structure

      • Perphenazine

      • Prochlorperazine

      • Trifluoperazine

    • N05AC: Phenothiazines with piperidine structure

    • N05AD: Butyrophenone derivatives

      • Haloperidol

    • N05AE: Indole derivatives

      • Lurasidone

    • N05AF: Thioxanthene derivatives

      • Flupenthixol Decanoate

      • Zuclopenthixol Decanoate

    • N05AG: Diphenylbutylpiperidine derivatives

    • N05AH: Diazepines, oxazepines, thiazepines and oxepines

      • Clozapine

      • Olanzapine

      • Quetiapine

    • N05AL: Benzamides

      • Amisulpride

      • Sulpiride

    • N05AN: Lithium

      • Lithium Carbonate

    • N05AX: Other antipsychotics

      • Aripiprazole

      • Brexpiprazole

      • Cariprazine

      • Paliperidone

      • Paliperidone Palmitate

      • Risperidone

  • N05B: Anxiolytics

    • N05BA: Benzodiazepine derivatives

      • Alprazolam

      • Bromazepam

      • Chlordiazepoxide

      • Clobazam

      • Diazepam

      • Lorazepam

      • Pinazepam

    • N05BB: Diphenylmethane derivatives

      • Hydroxyzine

    • N05BC: Carbamates

    • N05BD: Dibenzo-bicyclo-octadiene derivatives

    • N05BE: Azaspirodecanedione derivatives

    • N05BX: Other anxiolytics

  • N05C: Hypnotics and sedatives

    • N05CA: Barbiturates, plain

    • N05CB: Barbiturates, combinations

    • N05CC: Aldehydes and derivatives

      • Paraldehyde

    • N05CD: Benzodiazepine derivatives

      • Midazolam

    • N05CE: Piperidinedione derivatives

    • N05CF: Benzodiazepine related drugs

      • Zolpidem

      • Zopiclone

    • N05CH: Melatonin receptor agonists

      • Melatonin

    • N05CJ: Orexin receptor antagonists

      • Lemborexant

    • N05CM: Other hypnotics and sedatives

      • Dexmedetomidine

    • N05CX: Hypnotics and sedatives in combination, excl. barbiturates

• N06: Psychoanaleptics

  • N06A: Antidepressants

    • N06AA: Non-selective monoamine reuptake inhibitors

      • Amitriptyline

      • Clomipramine

      • Dothiepin

      • Imipramine

      • Nortriptyline

    • N06AB: Selective serotonin reuptake inhibitors

      • Escitalopram

      • Fluoxetine

      • Fluvoxamine

      • Paroxetine

      • Sertraline

    • N06AF: Monoamine oxidase inhibitors, non-selective

    • N06AG: Monoamine oxidase A inhibitors

      • Moclobemide

    • N06AX: Other antidepressants

      • Agomelatine

      • Bupropion

      • Desvenlafaxine

      • Duloxetine

      • Esketamine

      • Mirtazapine

      • Tianeptine

      • Trazodone

      • Venlafaxine

      • Vortioxetine

  • N06B: Psychostimulants, agents used for ADHD and nootropics

    • N06BA: Centrally acting sympathomimetics

      • Lisdexamfetamine Dimesylate

      • Methylphenidate

    • N06BC: Xanthine derivatives

      • Caffeine

    • N06BX: Other psychostimulants and nootropics

      • Piracetam

      • Vinpocetine

  • N06C: Psycholeptics and psychoanaleptics in combination

    • N06CA: Antidepressants in combination with psycholeptics

      • Flupenthixol + Melitracen

    • N06CB: Psychostimulants in combination with psycholeptics

  • N06D: Anti-dementia drugs

    • N06DA: Anticholinesterases

      • Donepezil

      • Galantamine

      • Rivastigmine

    • N06DX: Other anti-dementia drugs

      • Memantine

• N07: Other nervous system drugs

  • N07A: Parasympathomimetics

    • N07AA: Anticholinesterases

      • Distigmine

      • Neostigmine

      • Pyridostigmine

    • N07AB: Choline esters

    • N07AX: Other parasympathomimetics

      • Pilocarpine

  • N07B: Drugs used in addictive disorders

    • N07BA: Drugs used in nicotine dependence

      • Nicotine

      • Varenicline

    • N07BB: Drugs used in alcohol dependence

      • Naltrexone

    • N07BC: Drugs used in opioid dependence

  • N07C: Antivertigo preparations

    • N07CA: Antivertigo preparations

      • Betahistine Dihydrochloride

      • Betahistine Mesilate

      • Cinnarizine

      • Flunarizine

  • N07X: Other nervous system drugs

    • N07XA: Gangliosides and ganglioside derivatives

    • N07XX: Other nervous system drugs

      • Riluzole

      • Tafamidis

      • Valbenazine

      • Vutrisiran

P: Antiparasitic products, insecticides and repellents

• P01: Antiprotozoals

  • P01A: Agents against amoebiasis and other protozoal diseases

    • P01AA: Hydroxyquinoline derivatives

    • P01AB: Nitroimidazole derivatives

      • Metronidazole

    • P01AC: Dichloroacetamide derivatives

    • P01AR: Arsenic compounds

    • P01AX: Other agents against amoebiasis and other protozoal diseases

  • P01B: Antimalarials

    • P01BA: Aminoquinolines

      • Chloroquine

      • Hydroxychloroquine

    • P01BB: Biguanides

      • Atovaquone + Proguanil

    • P01BC: Methanolquinolines

    • P01BD: Diaminopyrimidines

    • P01BE: Artemisinin and derivatives, plain

      • Artesunate

    • P01BF: Artemisinin and derivatives, combinations

    • P01BX: Other antimalarials

  • P01C: Agents against leishmaniasis and trypanosomiasis

    • P01CA: Nitroimidazole derivatives

    • P01CB: Antimony compounds

    • P01CC: Nitrofuran derivatives

    • P01CD: Arsenic compounds

    • P01CX: Other agents against leishmaniasis and trypanosomiasis

      • Pentamidine Isethionate

• P02: Anthelmintics

  • P02B: Antitrematodals

    • P02BA: Quinoline derivatives and related substances

      • Praziquantel

    • P02BB: Organophosphorous compounds

    • P02BX: Other antitrematodal agents

  • P02C: Antinematodal agents

    • P02CA: Benzimidazole derivatives

      • Albendazole

    • P02CB: Piperazine and derivatives

      • Piperazine

    • P02CC: Tetrahydropyrimidine derivatives

    • P02CE: Imidazothiazole derivatives

    • P02CF: Avermectines

    • P02CX: Other antinematodals

  • P02D: Anticestodals

    • P02DA: Salicylic acid derivatives

    • P02DX: Other anticestodals

• P03: Ectoparasiticides, incl. scabicides, insecticides and repellents

  • P03A: Ectoparasiticides, incl. scabicides

    • P03AA: Sulfur containing products

    • P03AB: Chlorine containing products

    • P03AC: Pyrethrines, incl. synthetic compounds

    • P03AX: Other ectoparasiticides, incl. scabicides

      • Benzyl Benzoate

      • Malathion

  • P03B: Insecticides and repellents

    • P03BA: Pyrethrines

    • P03BX: Other insecticides and repellents

R: Respiratory system

• R01: Nasal preparations

  • R01A: Decongestants and other nasal preparations for topical use

    • R01AA: Sympathomimetics, plain

      • Ephedrine Hydrochloride

      • Oxymetazoline

      • Xylometazoline

    • R01AB: Sympathomimetics, combinations excl. corticosteroids

      • Chlorpheniramine + Naphazoline

    • R01AC: Antiallergic agents, excl. corticosteroids

    • R01AD: Corticosteroids

      • Azelastine + Fluticasone Propionate

      • Beclomethasone

      • Budesonide

      • Fluticasone Furoate

      • Fluticasone Propionate

      • Mometasone

      • Mometasone + Olopatadine

    • R01AX: Other nasal preparations

      • Mupirocin

  • R01B: Nasal decongestants for systemic use

    • R01BA: Sympathomimetics

      • Carbinoxamine + Pseudoephedrine

      • Cetirizine + Pseudoephedrine

      • Desloratadine + Pseudoephedrine

      • Dexchlorpheniramine + Pseudoephedrine

      • Fexofenadine + Pseudoephedrine

      • Loratadine + Pseudoephedrine

      • Pseudoephedrine

      • Pseudoephedrine + Triprolidine

• R02: Throat preparations

  • R02A: Throat preparations

    • R02AA: Antiseptics

      • Amylmetacresol + Dichlorobenzyl Alcohol + Lidocaine

      • Benzalkonium + Benzocaine + Tyrothricin

      • Benzocaine + Chlorhexidine

      • Dichlorobenzyl Alcohol + Benzydamine + Lidocaine

      • Povidone-Iodine

    • R02AB: Antibiotics

    • R02AD: Anesthetics, local

      • Dichlorobenzyl Alcohol + Benzydamine + Lidocaine

      • Lidocaine

    • R02AX: Other throat preparations

      • Benzydamine

      • Benzydamine + Cetylpyridinium

      • Flurbiprofen

• R03: Drugs for obstructive airway diseases

  • R03A: Adrenergics, inhalants

    • R03AA: Alpha- and beta-adrenoreceptor agonists

    • R03AB: Non-selective beta-adrenoreceptor agonists

    • R03AC: Selective beta-2-adrenoreceptor agonists

      • Formoterol

      • Salbutamol

    • R03AH: Combinations of adrenergics

    • R03AK: Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics

      • Beclomethasone + Formoterol

      • Budesonide + Formoterol

      • Fluticasone Furoate + Vilanterol

      • Fluticasone Propionate + Formoterol

      • Fluticasone Propionate + Salmeterol

      • Indacaterol + Mometasone

    • R03AL: Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids

      • Beclomethasone + Formoterol + Glycopyrronium

      • Budesonide + Formoterol + Glycopyrronium

      • Fenoterol + Ipratropium

      • Fluticasone Furoate + Umeclidinium + Vilanterol

      • Glycopyrronium + Indacaterol

      • Glycopyrronium + Indacaterol + Mometasone

      • Ipratropium + Salbutamol

      • Olodaterol + Tiotropium

      • Umeclidinium + Vilanterol

  • R03B: Other drugs for obstructive airway diseases, inhalants

    • R03BA: Glucocorticoids

      • Beclomethasone

      • Budesonide

      • Fluticasone Propionate

      • Mometasone

    • R03BB: Anticholinergics

      • Glycopyrronium

      • Ipratropium

      • Revefenacin

      • Tiotropium

      • Umeclidinium

    • R03BC: Antiallergic agents, excl. corticosteroids

    • R03BX: Other drugs for obstructive airway diseases, inhalants

  • R03C: Adrenergics for systemic use

    • R03CA: Alpha- and beta-adrenoreceptor agonists

    • R03CB: Non-selective beta-adrenoreceptor agonists

    • R03CC: Selective beta-2-adrenoreceptor agonists

      • Salbutamol

      • Terbutaline

    • R03CK: Adrenergics and other drugs for obstructive airway diseases

  • R03D: Other systemic drugs for obstructive airway diseases

    • R03DA: Xanthines

      • Aminophylline

      • Theophylline

    • R03DB: Xanthines and adrenergics

    • R03DC: Leukotriene receptor antagonists

      • Montelukast

    • R03DX: Other systemic drugs for obstructive airway diseases

      • Benralizumab [Fasenra]

      • Benralizumab

      • Mepolizumab [Nucala]

      • Mepolizumab

      • Omalizumab [Xolair]

      • Omalizumab

      • Tezepelumab [Tezspire]

      • Tezepelumab

• R05: Cough and cold preparations

  • R05C: Expectorants, excl. combinations with cough suppressants

    • R05CA: Expectorants

      • Ammonium Chloride + Ephedrine Hydrochloride + Guaifenesin

      • Ammonium Chloride + Ephedrine Hydrochloride + Sodium Citrate

      • Dextromethorphan + Guaifenesin

      • Diphenhydramine + Ammonium Chloride with or without Sodium Citrate (Compound Diphenhydramine)

      • Guaifenesin

      • Guaifenesin + Pseudoephedrine

      • Liquorice + Ipecacuanha + Squill + Tolu

    • R05CB: Mucolytics

      • Acetylcysteine

      • Ambroxol

      • Bromhexine

      • Carbocisteine

      • Erdosteine

  • R05D: Cough suppressants, excl. combinations with expectorants

    • R05DA: Opium alkaloids and derivatives

      • Apricot Kernel Extract + Glycyrrhiza Extract + Noscapine

      • Chlorpheniramine + Codeine + Ephedrine Hydrochloride

      • Codeine

      • Codeine + Ephedrine Hydrochloride + Promethazine Hydrochloride

      • Codeine + Phenyltoloxamine

      • Codeine + Promethazine Hydrochloride

      • Codeine + Pseudoephedrine + Triprolidine

      • Dexchlorpheniramine + Dextromethorphan + Pseudoephedrine

      • Dextromethorphan

      • Dextromethorphan + Ephedrine Hydrochloride + Promethazine Hydrochloride

      • Dextromethorphan + Promethazine Hydrochloride + Pseudoephedrine

      • Dextromethorphan + Pseudoephedrine + Triprolidine

    • R05DB: Other cough suppressants

  • R05F: Cough suppressants and expectorants, combinations

    • R05FA: Opium derivatives and expectorants

      • Ammonium Chloride + Chlorpheniramine + Codeine + Ephedrine Hydrochloride

      • Ammonium Chloride + Codeine + Diphenhydramine

      • Guaifenesin + Noscapine

    • R05FB: Other cough suppressants and expectorants

      • Ammonium Chloride + Dextromethorphan + Diphenhydramine

      • Ammonium Chloride + Dextromethorphan + Ephedrine Hydrochloride

  • R05X: Other cold preparations

• R06: Anthistamines for systemic use

  • R06A: Anthistamines for systemic use

    • R06AA: Aminoalkyl ethers

      • Dimenhydrinate

      • Diphenhydramine

      • Diphenhydramine + Ephedrine Hydrochloride

      • Doxylamine + Vitamin B6

    • R06AB: Substituted alkylamines

      • Brompheniramine

      • Chlorpheniramine

      • Chlorpheniramine + Pseudoephedrine

      • Dexchlorpheniramine

    • R06AC: Substituted ethylene diamines

    • R06AD: Phenothiazine derivatives

      • Carbocisteine + Promethazine Hydrochloride

      • Promethazine Hydrochloride

      • Promethazine Theoclate

    • R06AE: Piperazine derivatives

      • Buclizine

      • Cetirizine

      • Cyclizine

      • Levocetirizine

    • R06AK: Combinations of antihistamines

    • R06AX: Other antihistamines for systemic use

      • Bilastine

      • Cyproheptadine

      • Desloratadine

      • Ebastine

      • Fexofenadine

      • Ketotifen

      • Loratadine

      • Rupatadine

• R07: Other respiratory system products

  • R07A: Other respiratory system products

    • R07AA: Lung surfactants

      • Phospholipids [Infasurf]

      • Phospholipids

    • R07AB: Respiratory stimulants

    • R07AX: Other respiratory system products

S: Sensory organs

• S01: Ophthalmologicals

  • S01A: Antiinfectives

    • S01AA: Antibiotics

      • Chloramphenicol

      • Chlortetracycline

      • Fusidic Acid

      • Gentamicin

      • Natamycin

      • Tobramycin

    • S01AB: Sulfonamides

    • S01AD: Antivirals

      • Ganciclovir

    • S01AE: Fluoroquinolones

      • Ciprofloxacin

      • Gatifloxacin

      • Levofloxacin

      • Moxifloxacin

    • S01AX: Other antiinfectives

      • Hexamidine Di-isethionate

  • S01B: Antiinflammatory agents

    • S01BA: Corticosteroids, plain

      • Dexamethasone

      • Fluorometholone

      • Loteprednol

      • Prednisolone

      • Triamcinolone

    • S01BB: Corticosteroids and mydriatics in combination

    • S01BC: Antiinflammatory agents, non-steroids

      • Ketorolac

      • Nepafenac

  • S01C: Antiinflammatory agents and antiinfectives in combination

    • S01CA: Corticosteroids and antiinfectives in combination

      • Dexamethasone + Gentamicin

      • Dexamethasone + Levofloxacin

      • Dexamethasone + Neomycin

      • Dexamethasone + Tobramycin

      • Loteprednol + Tobramycin

      • Neomycin + Polymyxin B + Dexamethasone

    • S01CB: Corticosteroids/antiinfectives/mydriatics in combination

    • S01CC: Antiinflammatory agents, non-steroids and antiinfectives in combination

  • S01E: Antiglaucoma preparations and miotics

    • S01EA: Sympathomimetics in glaucoma therapy

      • Brimonidine

    • S01EB: Parasympathomimetics

      • Carbachol

      • Pilocarpine

    • S01EC: Carbonic anhydrase inhibitors

      • Acetazolamide

      • Brimonidine + Brinzolamide

      • Brinzolamide

      • Dorzolamide

    • S01ED: Beta blocking agents

      • Bimatoprost + Timolol

      • Brimonidine + Timolol

      • Brinzolamide + Timolol

      • Dorzolamide + Timolol

      • Latanoprost + Timolol

      • Tafluprost + Timolol

      • Timolol

      • Timolol + Travoprost

    • S01EE: Prostaglandin analogues

      • Bimatoprost

      • Latanoprost

      • Latanoprost + Netarsudil

      • Latanoprostene Bunod

      • Tafluprost

      • Travoprost

    • S01EX: Other antiglaucoma preparations

      • Netarsudil

      • Omidenepag Isopropyl

      • Ripasudil

  • S01F: Mydriatics and cycloplegics

    • S01FA: Anticholinergics

      • Atropine

      • Cyclopentolate

      • Tropicamide

    • S01FB: Sympathomimetics excl. antiglaucoma preparations

      • Phenylephrine

  • S01G: Decongestants and antiallergics

    • S01GA: Sympathomimetics used as decongestants

      • Naphazoline + Pheniramine

      • Tetryzoline

    • S01GX: Other antiallergics

      • Cromoglicic Acid

      • Olopatadine

      • Spaglumic Acid

  • S01H: Local anesthetics

    • S01HA: Local anesthetics

      • Proparacaine

      • Tetracaine

  • S01J: Diagnostic agents

    • S01JA: Colouring agents

    • S01JX: Other ophthalmological diagnostic agents

  • S01K: Surgical aids

    • S01KA: Viscoelastic substances

    • S01KX: Other surgical aids

  • S01L: Ocular vascular disorder agents

    • S01LA: Antineovascularisation agents

      • Aflibercept [Eylea]

      • Aflibercept

      • Faricimab [Vabysmo]

      • Faricimab

      • Ranibizumab [Lucentis]

      • Ranibizumab

      • Verteporfin

  • S01X: Other ophthalmologicals

    • S01XA: Other ophthalmologicals

      • Ciclosporin

      • Pirenoxine

      • Sodium Chloride

      • Sodium Chloride + Calcium Chloride Dihydrate + Potassium Chloride

• S02: Otologicals

  • S02A: Antiinfectives

    • S02AA: Antiinfectives

      • Chloramphenicol

      • Ciprofloxacin

      • Ciprofloxacin + Hydrocortisone

      • Clotrimazole

  • S02B: Corticosteroids

    • S02BA: Corticosteroids

  • S02C: Corticosteroids and antiinfectives in combination

    • S02CA: Corticosteroids and antiinfectives in combination

      • Ciprofloxacin + Fluocinolone

      • Dexamethasone + Neomycin

      • Neomycin + Polymyxin B + Dexamethasone

  • S02D: Other otologicals

    • S02DA: Analgesics and anesthetics

      • Phenazone

    • S02DC: Indifferent preparations

• S03: Ophthalmological and otological preparations

  • S03A: Antiinfectives

    • S03AA: Antiinfectives

      • Ciprofloxacin

  • S03B: Corticosteroids

    • S03BA: Corticosteroids

  • S03C: Corticosteroids and antiinfectives in combination

    • S03CA: Corticosteroids and antiinfectives in combination

      • Dexamethasone + Neomycin

  • S03D: Other ophthalmological and otological preparations